<SEC-DOCUMENT>0001104659-26-023534.txt : 20260304
<SEC-HEADER>0001104659-26-023534.hdr.sgml : 20260304
<ACCEPTANCE-DATETIME>20260304165947
ACCESSION NUMBER:		0001104659-26-023534
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20260304
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260304
DATE AS OF CHANGE:		20260304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AbbVie Inc.
		CENTRAL INDEX KEY:			0001551152
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				320375147
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35565
		FILM NUMBER:		26722471

	BUSINESS ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
		BUSINESS PHONE:		(847) 932-7900

	MAIL ADDRESS:	
		STREET 1:		1 NORTH WAUKEGAN ROAD
		CITY:			NORTH CHICAGO
		STATE:			IL
		ZIP:			60064
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm266774d4_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:abbv="http://abbvie.com/20260304">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_027_US%2DGAAP%2D2025_exch -->
<!-- Field: Set; Name: xdx; ID: xdx_032_abbv_abbvie.com_20260304 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20260304_20260304 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DEntityCentralIndexKey_0001551152 -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_T%2D%2D\DeptFiles%2DiXBRL 8%2DK Covers Templates\+++%2DROOT%2DElement%2D+++\DocumentInformationLineItems.xdxs -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Arial, Helvetica, Sans-Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000004" name="dei:EntityCentralIndexKey">0001551152</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember" id="xdx2ixbrl0046" name="dei:Security12bTitle">Common Stock, $0.01 Par Value</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember" id="xdx2ixbrl0047" name="dei:TradingSymbol">ABBV</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="abbv-20260304.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-03-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes0.750Percentdue2027Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2028Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.625Percentdue2028Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2029Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001551152</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes1.250Percentdue2031Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-03-04</xbrli:startDate>
        <xbrli:endDate>2026-03-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0"></p>

<p style="margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="margin: 0pt 0">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">UNITED
STATES</span></p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Washington,
D.C. 20549</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM <span id="xdx_905_edei--DocumentType_c20260304__20260304_zONMsRjw0N27"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CURRENT
REPORT</span></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13  OR 15(d) of the</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event
reported):</b> <b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20260304__20260304_zJXL61WceCJk"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">March 4, 2026</ix:nonNumeric>
</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 20pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_903_edei--EntityRegistrantName_c20260304__20260304_zMxboypAgKaf" style="font-size: 18pt"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000012" name="dei:EntityRegistrantName">ABBVIE
INC.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20260304__20260304_z2WowNJNdUB9"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt-sec:stateprovnameen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td>
    <td style="width: 2%; font-weight: bold; text-align: center">&#160;</td>
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_903_edei--EntityFileNumber_c20260304__20260304_znVP6Te9BH58"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000014" name="dei:EntityFileNumber">001-35565</ix:nonNumeric></span></td>
    <td style="width: 2%; font-weight: bold; text-align: center">&#160;</td>
    <td style="width: 32%; font-weight: bold; text-align: center"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20260304__20260304_zOJRI7yDTHfl"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000015" name="dei:EntityTaxIdentificationNumber">32-0375147</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center"><b>(State of Incorporation)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>(Commission <br/>
File Number)</b></td>
    <td style="text-align: center"><b>&#160;</b></td>
    <td style="text-align: center"><b>(IRS Employer<br/> Identification Number)</b></td></tr>
</table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 1pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_903_edei--EntityAddressAddressLine1_c20260304__20260304_zZ3jhjyFtTEl"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000016" name="dei:EntityAddressAddressLine1">1
North Waukegan Road</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90C_edei--EntityAddressCityOrTown_c20260304__20260304_z9EY4weOz3Ic"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000017" name="dei:EntityAddressCityOrTown">North
Chicago</ix:nonNumeric></span>, <span id="xdx_90A_edei--EntityAddressStateOrProvince_c20260304__20260304_z5ikukxG6o25"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Illinois</ix:nonNumeric></span> <span id="xdx_902_edei--EntityAddressPostalZipCode_c20260304__20260304_zzTpfMyDRaWd"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000019" name="dei:EntityAddressPostalZipCode">60064-6400</ix:nonNumeric></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>(Address
of principal executive offices, including zip code)&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(<span id="xdx_90A_edei--CityAreaCode_c20260304__20260304_zGZE6WnHbLbe"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000020" name="dei:CityAreaCode">847</ix:nonNumeric></span></b><b>)
<span id="xdx_901_edei--LocalPhoneNumber_c20260304__20260304_zT4aTWfBKXp5"><ix:nonNumeric contextRef="AsOf2026-03-04" id="Fact000021" name="dei:LocalPhoneNumber">932-7900</ix:nonNumeric></span></b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<b>Registrant&#8217;s telephone
number, including area code</b>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_906_edei--WrittenCommunications_c20260304__20260304_zBiAsKIHVcwi"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_90F_edei--SolicitingMaterial_c20260304__20260304_zdXvuu90vxQ4"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementTenderOffer_c20260304__20260304_zDMJexAzFBb2"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>

<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-bottom: 1pt; width: 0.25in"><span style="font-family: Wingdings"><span id="xdx_908_edei--PreCommencementIssuerTenderOffer_c20260304__20260304_zVbuvJDcpyM1"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td>
    <td style="padding-bottom: 1pt; text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left">Emerging growth company <span style="font-family: Wingdings"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20260304__20260304_zZxjqbB9Ryl"><ix:nonNumeric contextRef="AsOf2026-03-04" format="ixt:booleanfalse" id="Fact000026" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; text-align: left">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Wingdings">&#168;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top">
    <td style="border-bottom: Black 1pt solid; width: 32%; font-weight: bold; text-align: center; padding-left: 5.4pt; vertical-align: bottom"><span style="font-size: 9pt">Title
    of each class</span></td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 32%; font-weight: bold; text-align: center; padding-left: 5.4pt; vertical-align: bottom"><span style="font-size: 9pt">Trading
    Symbol(s)</span></td>
    <td style="width: 2%; font-weight: bold; text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 32%; font-weight: bold; text-align: center"><span style="font-size: 9pt">Name
    of each exchange on which registered</span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 5.4pt"><span id="xdx_900_edei--Security12bTitle_c20260304__20260304__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_zDE7mysrSHhj" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS" id="Fact000027" name="dei:Security12bTitle">Common
    Stock, $0.01 Par Value</ix:nonNumeric></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_edei--TradingSymbol_c20260304__20260304__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_zI7Ad6cv5z3a" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS" id="Fact000028" name="dei:TradingSymbol">ABBV</ix:nonNumeric></span></td>
    <td style="text-align: center"><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_edei--SecurityExchangeName_c20260304__20260304__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember__dei--EntityListingsExchangeAxis__exch--XNYS_z0U6iCBfKrn7" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000029" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span> <span style="font-size: 9pt"><br/><span id="xdx_903_edei--SecurityExchangeName_c20260304__20260304__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_ztjQvCOXFB24"><ix:nonNumeric contextRef="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember" format="ixt-sec:exchnameen" id="Fact000030" name="dei:SecurityExchangeName">NYSE</ix:nonNumeric></span> Texas</span></td></tr>

<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90C_edei--Security12bTitle_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zDHGSWHztNGh" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" id="Fact000031" name="dei:Security12bTitle">0.750%
    Senior Notes due 2027</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_900_edei--TradingSymbol_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zQMkJfuY0V1k" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" id="Fact000032" name="dei:TradingSymbol">ABBV27</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_90D_edei--SecurityExchangeName_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes0.750Percentdue2027Member__dei--EntityListingsExchangeAxis__exch--XNYS_zaTl1ShNkxsc" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000033" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90F_edei--Security12bTitle_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zi4PiBY2v4nf" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" id="Fact000034" name="dei:Security12bTitle">2.125%
    Senior Notes Due 2028</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_905_edei--TradingSymbol_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zFm7ZBU7WXv4" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" id="Fact000035" name="dei:TradingSymbol">ABBV28</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_edei--SecurityExchangeName_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zHL4s25gFXAe" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000036" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_903_edei--Security12bTitle_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zEU8ZrVZPjhd" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" id="Fact000037" name="dei:Security12bTitle">2.625%
    Senior Notes Due 2028</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_907_edei--TradingSymbol_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zTFwjGS5m1S8" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" id="Fact000038" name="dei:TradingSymbol">ABBV28B</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_905_edei--SecurityExchangeName_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.625Percentdue2028Member__dei--EntityListingsExchangeAxis__exch--XNYS_zA0LBU64B9r" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000039" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_90E_edei--Security12bTitle_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_zg1ezmSArN7e" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" id="Fact000040" name="dei:Security12bTitle">2.125%
    Senior Notes due 2029</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_903_edei--TradingSymbol_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_zQV6RhbMFi6c" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" id="Fact000041" name="dei:TradingSymbol">ABBV29</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_907_edei--SecurityExchangeName_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes2.125Percentdue2029Member__dei--EntityListingsExchangeAxis__exch--XNYS_z2FfEqA2Hpwl" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000042" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span id="xdx_902_edei--Security12bTitle_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zrqbWWElfiff" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" id="Fact000043" name="dei:Security12bTitle">1.250%
    Senior Notes due 2031</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_908_edei--TradingSymbol_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zDGNsCnWsiMl" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" id="Fact000044" name="dei:TradingSymbol">ABBV31</ix:nonNumeric></span></td>
    <td><span style="font-size: 9pt">&#160;</span></td>
    <td style="text-align: center"><span id="xdx_904_edei--SecurityExchangeName_c20260304__20260304__us-gaap--StatementClassOfStockAxis__custom--SeniorNotes1.250Percentdue2031Member__dei--EntityListingsExchangeAxis__exch--XNYS_zK2clSiZwSUh" style="font-size: 9pt"><ix:nonNumeric contextRef="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS" format="ixt-sec:exchnameen" id="Fact000045" name="dei:SecurityExchangeName">New
    York Stock Exchange</ix:nonNumeric></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table border="0" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
<td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--Security12bTitle_dxL_c20260304__20260304__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zunXS465MAQ1" style="display: none; visibility: hidden"><span style="-sec-ix-hidden: xdx2ixbrl0046">Common Stock, $0.01 Par Value</span></span></span></td>
<td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--TradingSymbol_dxL_c20260304__20260304__dei--EntityListingsExchangeAxis__exch--XCHI__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zLxboeuH8Rqa" style="display: none; visibility: hidden"><span style="-sec-ix-hidden: xdx2ixbrl0047">ABBV</span></span></span></td>
</tr>
<tr style="vertical-align: top">
<td style="text-align: center"><span id="xdx_910_eexch--XCHI_zBfmNmFBqU2d" style="display: none; visibility: hidden">NYSE TEXAS (Member)</span></td>
<td style="text-align: center">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font-size: 10pt"></p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01. Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;4, 2026, AbbVie
Inc. (&#8220;<span style="text-decoration: underline">AbbVie</span>&#8221;) completed its previously announced underwritten public offering (the &#8220;<span style="text-decoration: underline">Notes Offering</span>&#8221;)
of $750,000,000 aggregate principal amount of its senior floating rate notes due 2028 (the &#8220;<span style="text-decoration: underline">Floating Rate Notes</span>&#8221;),
$1,500,000,000 aggregate principal amount of its 3.775% senior notes due 2028 (the &#8220;<span style="text-decoration: underline">2028 Notes</span>&#8221;), $1,250,000,000 aggregate
principal amount of its 4.125% senior notes due 2031 (the &#8220;<span style="text-decoration: underline">2031 Notes</span>&#8221;), $1,250,000,000 aggregate principal amount
of its 4.400% senior notes due 2033 (the &#8220;<span style="text-decoration: underline">2033 Notes</span>&#8221;), $1,500,000,000 aggregate principal amount of its 4.750% senior
notes due 2036 (the &#8220;<span style="text-decoration: underline">2036 Notes</span>&#8221;), $1,250,000,000 aggregate principal amount of its 5.550% senior notes due 2056 (the
&#8220;<span style="text-decoration: underline">2056 Notes</span>&#8221;) and $500,000,000 aggregate principal amount of its 5.650% senior notes due 2066 (the &#8220;<span style="text-decoration: underline">2066
Notes</span>&#8221; and, together with the 2028 Notes, the 2031 Notes, the 2033 Notes, the 2036 Notes and the 2056 Notes, the &#8220;<span style="text-decoration: underline">Fixed
Rate Notes</span>&#8221; and, together with the Floating Rate Notes, the &#8220;<span style="text-decoration: underline">Notes</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The offering of each series
of Notes was registered under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline">Act</span>&#8221;), pursuant to AbbVie&#8217;s registration
statement on Form&#160;S-3ASR (File No.&#160;333-284980) (the &#8220;<span style="text-decoration: underline">Registration Statement</span>&#8221;) dated as of February&#160;14,
2025. The terms of the Notes are further described in AbbVie&#8217;s prospectus supplement dated February&#160;24, 2026, as filed with
the Securities and Exchange Commission pursuant to Rule&#160;424(b)(5)&#160;of the Act on February&#160;26, 2026.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Notes are governed by
the Indenture, dated November&#160;8, 2012 (the &#8220;<span style="text-decoration: underline">Base Indenture</span>&#8221;), between AbbVie and U.S. Bank Trust Company, National
Association, as successor-in-interest to U.S. Bank National Association, as trustee (the &#8220;<span style="text-decoration: underline">Trustee</span>&#8221;), as supplemented
by that certain Supplemental Indenture No.&#160;12, dated as of March&#160;4, 2026, with respect to the Notes (the &#8220;<span style="text-decoration: underline">Supplemental
Indenture</span>&#8221; and, together with the Base Indenture as so supplemented, the &#8220;<span style="text-decoration: underline">Indenture</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Floating Rate Notes and
the 2028 Notes will mature on March&#160;3, 2028. All other series of Notes will mature on March&#160;15 of the applicable year. The Notes
are unsecured, unsubordinated obligations of AbbVie and will rank equally in right of payment with all of AbbVie&#8217;s existing and
future unsecured, unsubordinated indebtedness, liabilities and other obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">AbbVie may optionally redeem
(i)&#160;the 2028 Notes in whole or in part at any time; (ii)&#160;the 2031 Notes in whole or in part at any time prior to February&#160;15,
2031 (the &#8220;<span style="text-decoration: underline">2031 Par Call Date</span>&#8221;)&#894; (iii)&#160;the 2033 Notes in whole or in part at any time prior to January&#160;15,
2033 (the &#8220;<span style="text-decoration: underline">2033 Par Call Date</span>&#8221;)&#894; (iv)&#160;the 2036 Notes in whole or in part at any time prior to December&#160;15,
2035 (the &#8220;<span style="text-decoration: underline">2036 Par Call Date</span>&#8221;)&#894; (v)&#160;the 2056 Notes in whole or in part at any time prior to September&#160;15,
2055 (the &#8220;<span style="text-decoration: underline">2056 Par Call Date</span>&#8221;); and (vi)&#160;the 2066 Notes in whole or in part at any time prior to September&#160;15,
2065 (the &#8220;<span style="text-decoration: underline">2066 Par Call Date</span>&#8221; and, together with the 2031 Par Call Date, the 2033 Par Call Date, the 2036 Par Call
Date and the 2056 Par Call Date, collectively, the &#8220;<span style="text-decoration: underline">Par Call Dates</span>&#8221;), each at a customary &#8220;make-whole&#8221;
redemption price calculated in a manner set forth in the applicable Notes. On or after the applicable Par Call Date in respect of a series
of Fixed Rate Notes (other than the 2028 Notes), AbbVie may redeem the Fixed Rate Notes of such series, in whole or in part, at any time
and from time to time, at a redemption price equal to 100% of the principal amount of the Fixed Rate Notes of such series being redeemed
plus accrued and unpaid interest thereon to but not including the redemption date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains customary
terms and covenants, including limitations on AbbVie&#8217;s ability and the ability of certain of its subsidiaries to incur liens securing
funded indebtedness and on AbbVie&#8217;s ability to consolidate or merge with or into, or convey, transfer or lease its properties and
assets substantially as an entirety to any person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary of the
Indenture does not purport to be complete and is qualified in its entirety by reference to the full text of the Base Indenture and the
Supplemental Indenture, which are attached as Exhibits 4.1 and 4.2, respectively, hereto and are incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;<span style="text-decoration: underline">Exhibits</span>. The following exhibits are provided as part
of this Form&#160;8-K:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; width: 4%; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1551152/000104746912010673/a2211869zex-4_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></a></td>
    <td style="padding: 0.25pt; text-align: justify; width: 96%; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1551152/000104746912010673/a2211869zex-4_1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indenture, dated November&#160;8, 2012, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee (incorporated by reference to Exhibit&#160;4.1 of Amendment No.&#160;5 to AbbVie&#8217;s Registration Statement on Form&#160;10 filed November&#160;16, 2012).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex4-2.htm" style="-sec-extract: exhibit">Supplemental Indenture No.&#160;12, dated March&#160;4, 2026, between AbbVie Inc. and U.S. Bank Trust Company, National Association, as trustee.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_001" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></a></td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_001" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of Floating Rate Note due 2028 (included in Exhibit&#160;4.2 hereto).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_002" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></a></td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_002" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form&#160;of 3.775% Note due 2028 (included in Exhibit&#160;4.2 hereto).</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_003" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex4-2.htm#a_003" style="-sec-extract: exhibit">Form&#160;of 4.125% Note due 2031 (included in Exhibit&#160;4.2 hereto).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_004" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex4-2.htm#a_004" style="-sec-extract: exhibit">Form&#160;of 4.400% Note due 2033 (included in Exhibit&#160;4.2 hereto).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_005" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex4-2.htm#a_005" style="-sec-extract: exhibit">Form&#160;of 4.750% Note due 2036 (included in Exhibit&#160;4.2 hereto).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_006" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex4-2.htm#a_006" style="-sec-extract: exhibit">Form&#160;of 5.550% Note due 2056 (included in Exhibit&#160;4.2 hereto). &#160;</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex4-2.htm#a_007" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex4-2.htm#a_007" style="-sec-extract: exhibit">Form&#160;of 5.650% Note due 2066 (included in Exhibit&#160;4.2 hereto).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify; font-size: 10pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex5-1.htm" style="-sec-extract: exhibit">Opinion of Wachtell, Lipton, Rosen&#160;&amp; Katz, dated March&#160;4, 2026, with respect to the Notes.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><a href="tm267894d1_ex5-1.htm" style="-sec-extract: exhibit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></a></td>
    <td style="padding: 0.25pt; text-align: justify"><a href="tm267894d1_ex5-1.htm" style="-sec-extract: exhibit">Consent of Wachtell, Lipton, Rosen&#160;&amp; Katz (included in Exhibit&#160;5.1 of this Current Report on Form&#160;8-K).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt">&#160;</td>
    <td style="padding: 0.25pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding: 0.25pt; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="padding: 0.25pt; text-align: justify">Cover Page&#160;Interactive Data File (embedded within the Inline XBRL document).</td></tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">
    <b>ABBVIE INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 3%">&#160;</td>
    <td style="width: 47%">&#160;</td>
    </tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March&#160;4, 2026</span></td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;/s/ Scott T. Reents</span></td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scott T. Reents</span></td>
    </tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="white-space: nowrap; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive Vice President, Chief Financial Officer</span></td>
    </tr>
  </table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjUEKwjAQRU/QOwxZi02D3XRpqSJWkSLiNthRgm2mTKK2R/KWxhZxGBiG/9//QszEmlamQYbzsirhiG3XaI9Q4RUZ7QWDI99sMwi3wptxnrX14/sDcwoMBiadq1QHYbQ+jcM6A6liuYhVCjLJUgWHnYi+ek72amq03ugGtK3hwNSxQa95mBKOuidL7TBWnZCdIZtBMpeT/AYlEwV7euoX8d1BWeYimo0TiTXTowuuovdovyQUDbahzk30f6MPBT5Kig== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>tm267894d1_ex4-2.htm
<DESCRIPTION>EXHIBIT 4.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 4.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>Execution Version</I></B></P>



<P STYLE="margin: 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SUPPLEMENTAL INDENTURE NO. 12</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$750,000,000 Floating Rate Senior Notes due 2028<BR>
$1,500,000,000 3.775% Senior Notes due 2028<BR>
$1,250,000,000 4.125% Senior Notes due 2031<BR>
$1,250,000,000 4.400% Senior Notes due 2033<BR>
$1,500,000,000 4.750% Senior Notes due 2036</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$1,250,000,000 5.550% Senior Notes due 2056</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$500,000,000 5.650% Senior Notes due 2066</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">SUPPLEMENTAL INDENTURE NO.
12, dated as of March&#8239;4, 2026 (this &ldquo;<B>Supplemental Indenture</B>&rdquo;), by and between ABBVIE INC., a Delaware corporation
(the &ldquo;<B>Company</B>&rdquo;) and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as successor-in-interest
to U.S. Bank National Association, as trustee (the &ldquo;<B>Trustee</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RECITALS OF THE COMPANY:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company has
heretofore executed and delivered to the Trustee an Indenture, dated as of November&#8239;8, 2012 (as heretofore supplemented or amended,
the &ldquo;<B>Indenture</B>&rdquo;), providing for the issuance from time to time of one or more series of Securities (as defined in
the Indenture);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Article&#8239;IX
of the Indenture provides for various matters with respect to any series of Securities issued under the Indenture to be established in
an indenture supplemental to the Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, Section&#8239;9.1(7)&#8239;of
the Indenture provides that the Company and the Trustee may enter into an indenture supplemental to the Indenture to establish the form
or terms of Securities of any series as permitted by Sections 2.1 and 3.1 of the Indenture; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, all the conditions
and requirements necessary to make this Supplemental Indenture, when duly executed and delivered, a valid and binding agreement in accordance
with its terms and for the purposes herein expressed have been performed and fulfilled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, THIS SUPPLEMENTAL
INDENTURE WITNESSETH:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For and in consideration
of the premises and the issuance of the series of Securities provided for herein, the Company and the Trustee mutually covenant and agree
for the equal and proportionate benefit of the respective Holders of the Securities of each such series as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&#8239;1</FONT><BR>
RELATION TO INDENTURE; DEFINITIONS; RULES OF CONSTRUCTION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.1&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Relation
to Indenture</I>.&#8239; This Supplemental Indenture constitutes an integral part of the Indenture and capitalized terms defined in the
Indenture that are used but not defined herein shall have the meanings assigned to such terms in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.2&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Definitions</I>.&#8239;
For all purposes of this Supplemental Indenture, the following terms shall have the respective meanings set forth in this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>2028 Notes</B>&rdquo;
has the meaning assigned to such term in <U>Section&#8239;2.1.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>2031 Notes</B>&rdquo;
has the meaning assigned to such term in <U>Section&#8239;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>2033 Notes</B>&rdquo;
has the meaning assigned to such term in <U>Section&#8239;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>2036 Notes</B>&rdquo;
has the meaning assigned to such term in <U>Section&#8239;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>2056 Notes</B>&rdquo;
has the meaning assigned to such term in <U>Section&#8239;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>2066 Notes</B>&rdquo;
has the meaning assigned to such term in <U>Section&#8239;2.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Definitive Note</B>&rdquo;
means a certificated Note that does not include the Global Notes Legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Depository</B>&rdquo;
means The Depository Trust Company, its nominees and their respective successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Floating Rate Notes</B>&rdquo;
has the meaning assigned to such term in <U>Section&#8239;2.1.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Global Notes Legend</B>&rdquo;
means the legend set forth in Exhibits A1 through A7 to this Supplemental Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Notes</B>&rdquo;
means the Floating Rate Notes, the 2028 Notes, the 2031 Notes, the 2033 Notes, the 2036 Notes, the 2056 Notes and the 2066 Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Notes Custodian</B>&rdquo;
means the custodian with respect to a Global Note (as appointed by the Depository) or any successor person thereto, who will initially
be the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Participants</B>&rdquo;
means members of, or participants in, the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.3&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendment
to Section&#8239;4.1 of the Indenture</I>.&#8239; Solely as it relates to the Notes, Section&#8239;4.1 of the Indenture shall be amended
by replacing subsection (1)(B)&#8239;with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">all of the Securities of such series not
                                            theretofore delivered to the Trustee for cancellation</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;have
become due and payable,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;will
become due and payable at their Stated Maturity within one year, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
redeemable at the Company&rsquo;s option, are to be called for redemption within one year under arrangements satisfactory to the Trustee
for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">and the Company, in the case of clause&#8239;(i),
(ii)&#8239;or (iii)&#8239;above, has irrevocably deposited or caused to be deposited with the Trustee funds in an amount sufficient to
pay and discharge the entire indebtedness on the Securities of such series not theretofore delivered to the Trustee for cancellation,
for principal of, premium, if any, and interest on the Securities of such series to the date of such deposit (in the case of Securities
which have become due and payable), or to their Stated Maturity or the Redemption Date, as the case may be, together with irrevocable
instructions from the Company directing the Trustee to apply such funds to the payment thereof at Stated Maturity or the Redemption Date,
as the case may be; provided that in connection with (x)&#8239;any discharge relating to any redemption that requires the payment of a
premium or (y)&#8239;any discharge if, on the date of deposit or, if earlier, notice of redemption, as applicable, interest payable to,
but excluding, such Stated Maturity or Redemption Date cannot be calculated, the amount deposited shall be sufficient for purposes of
the Indenture to the extent that an amount is deposited with the Trustee equal to the interest, or premium, respectively, calculated
as of the date of deposit or, if earlier, notice of redemption, with the amount of any deficit as of such Stated Maturity or Redemption
Date only required to be deposited with the Trustee on or prior to such Stated Maturity Redemption Date; provided, further, that the
amount of any such deficit shall be set forth in an Officers&rsquo; Certificate, delivered to the Trustee simultaneously with the amount
of such deficit, confirming that such amount shall be applied to the interest, premium or other amounts payable at such Stated Maturity
or on such Redemption Date, as applicable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.4&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendment
to Section&#8239;5.1 to the Indenture</I>. Solely as it relates to the Notes, Section&#8239;5.1 of the Indenture shall be amended by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;replacing
subsection (4)&#8239;with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;default in the performance, or
breach, of any covenant or warranty of the Company in this Indenture (other than a covenant or warranty a default in whose performance
or whose breach is elsewhere in this Section&#8239;specifically dealt with or which has expressly been included in this Indenture solely
for the benefit of series of Securities other than that series), and continuance of such default or breach for a period of 90 days after
the giving of written notice to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal
amount of the Outstanding Securities of that series a written notice specifying such default or breach and requiring it to be remedied
and stating that such notice is a &ldquo;Notice of Default&rdquo; hereunder (provided that such notice may not be given with respect
to any action taken, and reported publicly or to Holders of the Securities more than two years prior to such notice)&#894;&rdquo; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;adding
the following paragraph at the end of Section&#8239;5.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;Any time period in this Indenture
to cure any actual or alleged default or Event of Default may be extended or stayed by a court of competent jurisdiction.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.5&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendment
to Section&#8239;11.2 of the Indenture</I>.&#8239; Solely as it relates to the Notes, Section&#8239;11.2 of the Indenture shall be amended
by replacing &ldquo;45 days&rdquo; with &ldquo;15 days&rdquo; therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.6&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendment
to Section&#8239;11.3 of the Indenture</I>.&#8239;Solely as it relates to the Notes, Section&#8239;11.3 of the Indenture shall be amended
by (a)&#8239;replacing &ldquo;45 days&rdquo; with &ldquo;15 days&rdquo; therein, in each instance thereof, and (b)&#8239;replacing &ldquo;by
random lot&rdquo; with &ldquo;pro rata, by lot or by such other method as the Trustee in its sole discretion deems appropriate and fair.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.7&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendment
to Section&#8239;11.4 of the Indenture</I>.&#8239;Solely as it relates to the Notes, Section&#8239;11.4 of the Indenture shall be amended
by:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;replacing
the first sentence therein with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;Notice of redemption shall be
given electronically or by first-class mail, postage prepaid to each Holder of Securities to be redeemed, at his or her address appearing
in the Security Register, or otherwise in accordance with the applicable procedures of The Depository Trust Company, sent or mailed not
less than 10 nor more than 60 days prior to the Redemption Date.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;adding
the following sentence to the end of Section&#8239;11.4 of the Indenture:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&ldquo;Any redemption or notice of redemption
may, at the Company&rsquo;s discretion, be subject to one or more conditions precedent, and, at the Company&rsquo;s discretion, the redemption
date may be delayed until such time as any or all such conditions shall be satisfied.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.8&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Amendment
to Section&#8239;13.4 of the Indenture</I>.<I>&#8239;</I>Solely as it relates to the Notes, Section&#8239;13.4 of the Indenture shall be
amended by replacing subsections (5)&#8239;and (6)&#8239;with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">In the case of an election under Section&#8239;13.2,
                                            the Company shall have delivered to the Trustee an Opinion of Counsel stating that (x)&#8239;the
                                            Company has received from, or there has been published by, the Internal Revenue Service a
                                            ruling, or (y)&#8239;since the date of this Indenture there has been a change in the applicable
                                            Federal income tax law, in either case to the effect that, and based thereon such opinion
                                            shall confirm that, the beneficial owners of the Outstanding Securities of such series will
                                            not recognize income, gain or loss for Federal income tax purposes as a result of such defeasance
                                            and will be subject to Federal income tax in the same manner as would have been the case
                                            if such defeasance had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(6)</TD><TD STYLE="text-align: justify">In the case of an election under Section&#8239;13.3,
                                            the Company shall have delivered to the Trustee an Opinion of Counsel to the effect that
                                            the beneficial owners of the Outstanding Securities of such series will not recognize income,
                                            gain or loss for Federal income tax purposes as a result of such covenant defeasance and
                                            will be subject to Federal income tax in the same manner as would have been the case if such
                                            covenant defeasance had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;1.9&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Rules&#8239;of
Construction</I>.&#8239; For all purposes of this Supplemental Indenture:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;capitalized
terms used herein without definition shall have the meanings specified in the Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;all
references herein to Articles and Sections, unless otherwise specified, refer to the corresponding Articles and Sections of this Supplemental
Indenture;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;the
terms &ldquo;herein,&rdquo; &ldquo;hereof,&rdquo; &ldquo;hereunder&rdquo; and other words of similar import refer to this Supplemental
Indenture; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;in
the event of a conflict with the definition of terms in the Indenture, the definitions in this Supplemental Indenture shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&#8239;2</FONT><BR>
THE SECURITIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;2.1&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Title
of the Notes</I>.&#8239; There shall be (i)&#8239;a series of Securities designated the Senior Floating Rate Notes due 2028 (the &ldquo;<B>Floating
Rate Notes</B>&rdquo;), (ii)&#8239;a series of Securities designated the 3.775% Senior Notes due 2028 (&ldquo;<B>2028 Notes</B>&rdquo;),
(iii)&#8239;a series of Securities designated the 4.125% Senior Notes due 2031 (&ldquo;<B>2031 Notes</B>&rdquo;), (iv)&#8239;a series of
Securities designated the 4.400% Senior Notes due 2033 (the &ldquo;<B>2033 Notes</B>&rdquo;), (v)&#8239;a series of Securities designated
the 4.750% Senior Notes due 2036 (the &ldquo;<B>2036 Notes</B>&rdquo;), (vi)&#8239;a series of Securities designated the 5.550% Senior
Notes due 2056 (the &ldquo;<B>2056 Notes</B>&rdquo;) and (vii)&#8239;a series of Securities designated the 5.650% Senior Notes due 2066
(the &ldquo;<B>2066 Notes</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;2.2&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Initial
Principal Amount</I>.&#8239; The 2028 Floating Rate Notes will be initially issued in an aggregate principal amount of $750,000,000, the
2028 Notes will be initially issued in an aggregate principal amount of $1,500,000,000, the 2031 Notes will be initially issued in an
aggregate principal amount of $1,250,000,000, the 2033 Notes will be initially issued in an aggregate principal amount of $1,250,000,000,
the 2036 Notes will be initially issued in an aggregate principal amount of $1,500,000,000, the 2056 Notes will be initially issued in
an aggregate principal amount of $1,250,000,000 and the 2066 Notes will be initially issued in an aggregate principal amount of $500,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;2.3&#9;&#8239;&#8239;&#8239;&#8239;&#8239;[<I>Reserved</I>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;2.4&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Form&#8239;and
Dating</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>General</I>.&#8239;
The Notes and the Trustee&rsquo;s certificate of authentication shall be substantially in the forms set forth in the corresponding Exhibits&#8239;A1-A7
hereto. The Notes may have notations, legends or endorsements required by law, stock exchange rule&#8239;or usage. Each Note shall be
dated the date of its authentication. The Notes shall be in denominations of $2,000 and integral multiples of $1,000 in excess thereof.
The Notes of each series and any additional Notes of such series subsequently issued under the Indenture will be treated as a single
series or class for all purposes under the Indenture, including, without limitation, waivers, amendments and redemptions; provided that,
if any such additional Notes are not fungible with the existing Notes for Federal income tax purposes, such additional Notes will have
a separate CUSIP number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The terms and provisions
contained in the Notes shall constitute, and are hereby expressly made, a part of this Supplemental Indenture, and the Company and the
Trustee, by their execution and delivery of this Supplemental Indenture, expressly agree to such terms and provisions and to be bound
thereby. However, to the extent any provision of any Note conflicts with the express provisions of this Supplemental Indenture, the provisions
of this Supplemental Indenture shall govern and be controlling.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby designates
The Depository Trust Company as the initial Depository for the Global Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Global
Notes</I>.&#8239; The Notes will be issued initially in the form of one or more global notes (the &ldquo;<B>Global Notes</B>&rdquo;) in
definitive, fully registered, book-entry form. The Global Notes will be delivered to the Notes Custodian and registered in the name of
the Depository or the nominee of such Depository. The aggregate principal amount of the Global Notes may from time to time be increased
or decreased by adjustments made on the records of the Trustee and the Depository or its nominee as hereinafter provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Book-Entry
Provisions</I>.&#8239; This Section&#8239;2.4(c)&#8239;shall apply only to a Global Note deposited with or on behalf of the Depository.
The Company shall execute and the Trustee shall, in accordance with this Section&#8239;2.4(c)&#8239;and pursuant to an order of the Company,
authenticate and deliver initially one or more Global Notes that (A)&#8239;shall be registered in the name of the Depository for such
Global Note or Global Notes or the nominee of such Depository and (B)&#8239;shall be delivered by the Trustee to such Depository or pursuant
to such Depository&rsquo;s instructions or held by the Trustee as Notes Custodian.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Payments</I>.&#8239;
Payments in respect of the principal of, premium, if any, and interest on a Global Note registered in the name of the Depository or its
nominee will be payable to the Depository in its capacity as the registered holder under the Indenture. Under the terms of the Indenture,
the Company, the Trustee and any agent of the Company or the Trustee will treat the persons in whose names the Notes, including the Global
Notes, are registered as the owners of the Notes for the purpose of receiving payments and for all other purposes, whether or not the
Notes be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. Notwithstanding
the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to
any written certification, proxy or other authorization furnished by the Depository or impair, as between the Depository and its Participants,
the operation of customary practices of such Depository governing the exercise of the rights of a holder of a beneficial interest in
any Global Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Definitive
Notes</I>.&#8239; Except as provided in Section&#8239;2.6, owners of a beneficial interest in the Global Notes will not have Notes registered
in their names, will not receive physical delivery of Definitive Notes and will not be considered the registered owners or &ldquo;holders&rdquo;
thereof under the Indenture for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;2.5&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Transfer
and Exchange</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Transfer
and Exchange of Definitive Notes</I>.&#8239; When Definitive Notes are presented to the Security Registrar with a request:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
register the transfer of such Definitive Notes; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;to
exchange such Definitive Notes for an equal principal amount of Definitive Notes of other authorized denominations, the Security Registrar
shall register the transfer or make the exchange as requested if its reasonable requirements for such transaction are met; provided,
however, that the Definitive Notes surrendered for transfer or exchange:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(A)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;shall
be duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the Security Registrar,
duly executed by the Holder thereof or his or her attorney duly authorized in writing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(B)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;are
accompanied by the following additional information and documents, as applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(x)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such Definitive Notes are being delivered to the Security Registrar by a Holder for registration in the name of such Holder, without
transfer, a certification from such Holder to that effect (in the form set forth on the reverse side of the Note); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">(y)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;if
such Definitive Notes are being transferred to the Company, a certification to that effect (in the form satisfactory to the Trustee).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Restrictions
on Transfer of a Definitive Note for a Beneficial Interest in a Global Note</I>.&#8239; A Definitive Note may not be exchanged for a beneficial
interest in a Global Note except upon satisfaction of the requirement set forth below. Upon receipt by the Trustee of a Definitive Note,
duly endorsed or accompanied by a written instrument of transfer in form reasonably satisfactory to the Company and the Security Registrar,
together with written instructions directing the Trustee to make, or to direct the Notes Custodian to make, an adjustment on its books
and records with respect to such Global Note to reflect an increase in the aggregate principal amount of the Notes represented by the
Global Note, such instructions to contain information regarding the Depository account to be credited with such increase, then the Trustee
shall cancel such Definitive Note and cause, or direct the Notes Custodian to cause, in accordance with the standing instructions and
procedures existing between the Depository and the Notes Custodian, the aggregate principal amount of Notes represented by the Global
Note to be increased by the aggregate principal amount of the Definitive Note to be exchanged and shall credit or cause to be credited
to the account of the Person specified in such instructions a beneficial interest in the Global Note equal to the principal amount of
the Definitive Note so canceled. If no Global Notes are then outstanding and the Global Note has not been previously exchanged for certificated
securities pursuant to Section&#8239;2.6, the Company shall issue and the Trustee shall authenticate, upon receipt of a Company Order,
a new Global Note in the appropriate principal amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Transfer
and Exchange of Global Notes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
transfer and exchange of Global Notes or beneficial interests therein shall be effected through the Depository, in accordance with this
Supplemental Indenture (including applicable restrictions on transfer set forth herein, if any) and the procedures of the Depository
therefor. A transferor of a beneficial interest in a Global Note shall deliver a written order given in accordance with the Depository&rsquo;s
procedures containing information regarding the Participant account of the Depository to be credited with a beneficial interest in such
Global Note or another Global Note, and such account shall be credited in accordance with such order with a beneficial interest in the
applicable Global Note, and the account of the Person making the transfer shall be debited by an amount equal to the beneficial interest
in the Global Note being transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;If
the proposed transfer is a transfer of a beneficial interest in one Global Note to a beneficial interest in another Global Note, the
Security Registrar shall reflect on its books and records the date and an increase in the principal amount of the Global Note to which
such interest is being transferred in an amount equal to the principal amount of the interest to be so transferred, and the Security
Registrar shall reflect on its books and records the date and a corresponding decrease in the principal amount of the Global Note from
which such interest is being transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Notwithstanding
any other provisions of this Supplemental Indenture (other than the provisions set forth in Section&#8239;2.6), a Global Note may not
be transferred as a whole except by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository
or another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a nominee of such successor
Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[<I>Reserved</I>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;[<I>Reserved</I>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Cancellation
or Adjustment of Global Note</I>. At such time as all beneficial interests in a Global Note have either been exchanged for Definitive
Notes, transferred, redeemed, repurchased or canceled, such Global Note shall be returned by the Depository to the Trustee for cancellation
or retained and canceled by the Trustee. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged
for Definitive Notes, transferred in exchange for an interest in another Global Note, redeemed, repurchased or canceled, the principal
amount of Notes represented by such Global Note shall be reduced, and an adjustment shall be made on the books and records of the Trustee
(if it is then the Notes Custodian for such Global Note) with respect to such Global Note, by the Trustee or the Notes Custodian, to
reflect such reduction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Obligations
with Respect to Transfers and Exchanges of Notes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
permit registrations of transfers and exchanges, the Company shall execute and the Trustee shall authenticate, Definitive Notes and Global
Notes at the Security Registrar&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;No
service charge shall be made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may
require payment of a sum sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith
(other than any such transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections
9.6 or 11.7 of the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Prior
to the due presentation for registration of transfer of any Note, the Company, the Trustee, the Paying Agent or the Security Registrar
may deem and treat the person in whose name a Note is registered as the absolute owner of such Note for the purpose of receiving payment
of principal of and interest on such Note and for all other purposes whatsoever, whether or not such Note is overdue, and none of the
Company, the Trustee, the Paying Agent or the Security Registrar shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Company hereby appoints the Trustee as Security Registrar for the Notes. Neither the Company nor the Security Registrar shall be required
to register the transfer of or exchange Notes of any series (i)&#8239;during a period beginning at the opening of business 15 days before
the day of the mailing of a notice of redemption of Notes of that series selected for redemption under Section&#8239;11.3 of the Indenture
and ending at the close of business on the day of such mailing, or (ii)&#8239;so selected for redemption in whole or in part, except the
unredeemed portion of any Note being redeemed in part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;All
Notes issued upon any transfer or exchange pursuant to the terms of this Supplemental Indenture shall evidence the same Debt and shall
be entitled to the same benefits under the Indenture as the Notes surrendered upon such transfer or exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<I>No
Obligation of the Trustee</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Trustee shall have no responsibility or obligation to any beneficial owner of a Global Note, any Participant in the Depository or any
other Person with respect to the accuracy of the records of the Depository or its nominee or of any Participant thereof, with respect
to any ownership interest in the Notes or with respect to the delivery to any Participant, beneficial owner or other Person (other than
the Depository) of any notice (including any notice of redemption or repurchase) or the payment of any amount, under or with respect
to such Notes. All notices and communications to be given to the Holders and all payments to be made to Holders under the Notes shall
be given or made only to the registered Holders (which shall be the Depository or its nominee in the case of a Global Note). The rights
of beneficial owners in any Global Note shall be exercised only through the Depository subject to the applicable rules&#8239;and procedures
of the Depository. The Trustee may rely and shall be fully protected in relying upon information furnished by the Depository with respect
to its Participants and any beneficial owners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
Trustee shall have no obligation or duty to monitor, determine or inquire as to compliance with any restrictions on transfer imposed
under this Supplemental Indenture or under applicable law with respect to any transfer of any interest in any Note (including any transfers
between or among Participants or beneficial owners in any Global Note) other than to require delivery of such certificates and other
documentation or evidence as are expressly required by, and to do so if and when expressly required by, the terms of this Supplemental
Indenture, and to examine the same to determine substantial compliance as to form with the express requirements hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;2.6&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Definitive
Notes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;A
Global Note deposited with the Depository or with the Trustee as Notes Custodian pursuant to Section&#8239;2.4 shall be transferred to
the beneficial owners thereof in the form of Definitive Notes in an aggregate principal amount equal to the principal amount of such
Global Note, in exchange for such Global Note, only if such transfer complies with Section&#8239;2.5 and (i)&#8239;the Depository (A)&#8239;notifies
the Company that the Depository is no longer willing or able to act as a depositary or clearing system for the Notes or (B)&#8239;ceases
to be a &ldquo;clearing agency&rdquo; registered under the Securities Exchange Act of 1934, as amended, and in either event, a successor
depositary or clearing system is not appointed by the Company within 90 days of such notice or cessation, (ii)&#8239;upon the occurrence
and continuation of an Event of Default and the Depository notifies the Trustee of its decision to exchange the Global Note for Definitive
Notes, or (iii)&#8239;the Company determines not to have the Notes represented by a Global Note.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Any
Global Note that is transferable to the beneficial owners thereof pursuant to this Section&#8239;2.6 shall be surrendered by the Depository
to the Trustee, to be so transferred, in whole or from time to time in part, without charge, and upon Company Order the Trustee shall
authenticate and deliver, upon such transfer of each portion of such Global Note, an equal aggregate principal amount of Definitive Notes
of authorized denominations. Any portion of a Global Note transferred pursuant to this Section&#8239;2.6 shall be executed, authenticated
and delivered only in denominations of $2,000 of principal amount and any integral multiple of $1,000 in excess thereof and registered
in such names as requested by or on behalf of the Depository (in accordance with its customary procedures).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;The
registered Holder of a Global Note may grant proxies and otherwise authorize any Person, including Participants and Persons that may
hold interests through Participants, to take any action which a Holder is entitled to take under the Indenture or the Notes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;In
the event of the occurrence of any of the events specified in Section&#8239;2.6(a)(i), (ii)&#8239;or (iii), the Company will promptly make
available to the Trustee a reasonable supply of Definitive Notes in fully registered form without interest coupons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase">Article&#8239;3</FONT><BR>
MISCELLANEOUS PROVISIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;3.1&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Ratification</I>.&#8239;
The Indenture, as supplemented and amended by this Supplemental Indenture, is in all respects hereby adopted, ratified and confirmed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;3.2&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Counterparts</I>.&#8239;
This Supplemental Indenture may be executed in any number of counterparts, each of which when so executed shall be deemed an original,
and all such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Supplemental Indenture
and of signature pages&#8239;by facsimile, PDF or other electronic transmission shall constitute effective execution and delivery of this
Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures
of the parties hereto transmitted by facsimile, PDF or other electronic transmission (e.g., www.docusign.com) shall constitute effective
execution and delivery of this Supplemental Indenture as to the other parties hereto shall be deemed to be their original signatures
for all purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The words &ldquo;execution,&rdquo; &ldquo;signed,&rdquo;
&ldquo;signature,&rdquo; and words of like import in this Supplemental Indenture and (solely as it relates to the Notes) in the Indenture
shall be deemed to include electronic signatures or electronic records, each of which shall be of the same legal effect, validity or
enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and
as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York
State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company agrees to assume all risks arising
out of the use of digital signatures and electronic methods to submit communications to the Trustee, including, without limitation, the
risk of the Trustee acting on unauthorized instructions, and the risk of interception and misuse by third parties, in each case, except
to the extent arising from the negligence or bad faith of the Trustee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;3.3&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Governing
Law</I>.&#8239; THIS SUPPLEMENTAL INDENTURE AND EACH NOTE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE
OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;3.4&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>Conflict
with Trust Indenture Act</I>.&#8239; If any provision hereof limits, qualifies or conflicts with a provision of the Trust Indenture Act
that is required under the Trust Indenture Act to be a part of and govern this Supplemental Indenture, the latter provision shall control.
If any provision of this Supplemental Indenture modifies or excludes any provision of the Trust Indenture Act that may be so modified
or excluded, the latter provision shall be deemed to apply to this Supplemental Indenture as so modified or to be excluded, as the case
may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#8239;3.5&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<I>The
Trustee</I>.&#8239; The recitals contained herein and in the Securities, except the Trustee&rsquo;s certificates of authentication, shall
be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness.&#8239; The Trustee makes no
representations as to the validity or sufficiency of this Supplemental Indenture or of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature pages&#8239;follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the parties hereto have caused
this Supplemental Indenture to be duly executed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;/s/ Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Executive Vice President, Chief Financial Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&#8239;to Supplemental Indenture</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;/s/ Linda Garcia</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Linda Garcia</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Vice President</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page&#8239;to Supplemental Indenture</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&#8239;A1</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_001"></A>[Form&#8239;of ]Senior Floating Rate Notes due
2028</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD><B>No.&#8239;[&#9679;]</B></TD>
  <TD STYLE="text-align: right"><B>&#8239;&#8239;&#8239;&#8239;&#8239;$[&#9679;]</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EC9</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YEC93</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Security
in a global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This global Security is exchangeable for Securities registered in the name of a Person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of
this Security as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another
nominee of the Depository) may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless this Security is presented
by an authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or
payment, and any Security issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in
the name of Cede&#8239;&amp; Co. or such other name as requested by an authorized representative of The Depository Trust Company and any
payment hereon is made to Cede&#8239;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL since&#8239;the registered owner hereof, Cede&#8239;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ABBVIE INC., a corporation
duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term includes any successor
Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises to pay to Cede&#8239;&amp;
Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [&#9679;] Dollars ($[&#9679;]), or such
other principal sum as may be indicated on the Schedule of Exchanges attached hereto, on March&#8239;3, 2028 and to pay interest thereon
from March&#8239;4, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, quarterly
in arrears on March&#8239;3, June&#8239;3, September&#8239;3 and December&#8239;3 in each year, commencing June&#8239;3, 2026, at a floating
rate equal to a benchmark rate, which will initially be Compounded SOFR (as defined below), plus a spread of 0.480% per annum, computed
on the basis of the actual number of days in an interest period and a 360-day year, until the principal hereof is paid or made available
for payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The interest so payable,
and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in
whose name this Security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for
such interest, which shall be the date that is fifteen (15) calendar days prior to the relevant Interest Payment Date (whether or not
a Business Day). Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on such
Regular Record Date and may either be paid to the Person in whose name this Security (or one or more Predecessor Securities) is registered
at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof
shall be given to Holders of Securities of this series not less than ten (10)&#8239;days prior to such Special Record Date, or be paid
at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this
series may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
will bear interest for each interest period at a rate determined by the Calculation Agent (as defined below), except as set forth below.
The calculation agent will be U.S. Bank Trust Company, National Association until such time as the Company appoints a successor calculation
agent (the &ldquo;<U>Calculation Agent</U>&rdquo;). The interest rate on the Securities of this series for a particular interest period
(as defined below) will be a per year rate equal to a benchmark rate, which will initially be Compounded SOFR, determined as described
below, plus a spread of 0.480% per year (the &ldquo;<U>spread</U>&rdquo;), computed on the basis of the actual number of days in an interest
period and a 360-day year. In no event will the interest rate on the Securities of this series be (i)&#8239;higher than the maximum rate
permitted by New York law as the same may be modified by U.S. law of general application or (ii)&#8239;lower than zero. The interest determination
date for an interest period will be the date that is two (2)&#8239;U.S. Government Securities Business Days (as defined below) before
the applicable Interest Payment Date. Promptly upon determination, the Calculation Agent will inform the Trustee and the Company, or
in certain circumstances described below, the Company or its designee (which may be an independent financial advisor or such other designee
of the Company (any of such entities, a &ldquo;<U>Designee</U>&rdquo;)) will inform the Trustee, in writing of the interest rate for
such interest period. Absent manifest error, the determination of the interest rate by the Calculation Agent, or in certain circumstances
described below, by the Company or its Designee, shall be binding and conclusive on the Holders of the Securities, the Trustee and the
Company. For the avoidance of doubt, in no event shall the Calculation Agent, Trustee, or Paying Agent be the Designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None of the Trustee, the
Paying Agent or the Calculation Agent shall be under any obligation (i)&#8239;to monitor, determine or verify the unavailability or cessation
of Compounded SOFR (or any other benchmark), or whether or when there has occurred, or to give notice to any other transaction party
of the occurrence of, any Benchmark Transition Event (as defined below) or related Benchmark Replacement Date (as defined below), (ii)&#8239;to
select, determine or designate any Benchmark Replacement (as defined below), or other successor or replacement benchmark index, or whether
any conditions to the designation of such a rate or index have been satisfied, (iii)&#8239;to select, determine or designate any Benchmark
Replacement Adjustment (as defined below), or other modifier to any replacement or successor index, or (iv)&#8239;to determine whether
or what Benchmark Replacement Conforming Changes (as defined below) are necessary or advisable, if any, in connection with any of the
foregoing, including, but not limited to, adjustments as to any alternative spread thereon, the business day convention, interest determination
dates or any other relevant methodology applicable to such substitute or successor benchmark. In connection with the foregoing, each
of the Trustee, Paying Agent and Calculation Agent shall be entitled to conclusively rely on any determinations made by the Company or
its Designee without independent investigation, and none will have any liability for actions taken at the direction of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any determination, decision
or election that may be made by the Company or its Designee in connection with a Benchmark Transition Event or a Benchmark Replacement,
including any determination with respect to a rate or adjustment or of the occurrence or non-occurrence of an event, circumstance or
date and any decision to take or refrain from taking any action or any selection, will be conclusive and binding absent manifest error,
may be made in the Company&rsquo;s or its Designee&rsquo;s sole discretion and, notwithstanding anything to the contrary in this Security
or the Indenture, will become effective without consent from any other party. None of the Trustee, the Calculation Agent or the Paying
Agent will have any responsibility or liability for any determination made by or on behalf of the Company or its Designee in connection
with a Benchmark Transition Event or a Benchmark Replacement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">None of the Trustee, the
Paying Agent or the Calculation Agent shall be responsible or liable for any inability, failure or delay on its part to perform any of
its duties set forth in this Security as a result of the unavailability of Compounded SOFR or other applicable Benchmark Replacement,
including as a result of any failure, inability, delay, error or inaccuracy on the part of any other transaction party in providing any
direction, instruction, notice or information required or contemplated by the terms of this Security and reasonably required for the
performance of such duties. None of the Trustee, Paying Agent or Calculation Agent shall be responsible or liable for the Company&rsquo;s
actions or omissions or for those of its Designee, or for any failure or delay in the performance by the Company or its Designee, nor
shall any of the Trustee, Paying Agent or Calculation Agent be under any obligation to oversee or monitor the Company&rsquo;s performance
or that of the Designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The term &ldquo;<U>interest
period</U>,&rdquo; with respect to the Securities of this series, means (i)&#8239;the period from, and including, the most recent Interest
Payment Date for such Securities (or, with respect to the initial interest period only, from and including March&#8239;4, 2026) to, but
excluding, the next succeeding Interest Payment Date for such Securities or (ii)&#8239;in the case of the last such period, from, and
including, the Interest Payment Date for such Securities immediately preceding the maturity date to, but excluding, the maturity date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>Compounded SOFR</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The interest rate on the
Securities of this series for each interest period will be equal to Compounded SOFR plus the spread. &ldquo;<U>Compounded SOFR</U>&rdquo;
will be determined by the Calculation Agent in accordance with the following formula (and the resulting percentage will be rounded, if
necessary, to the nearest one hundred-thousandth of a percentage point, <I>e.g.</I>, 3.753973% (or .03753973) being rounded down to 3.75397%
(or .0375397) and 3.753978% (or .03753978) being rounded up to 3.75398% (or .0375398)):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm267894d1_ex4-2img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>SOFR Index<SUB>Start</SUB></U></I>&rdquo;
is the SOFR Index value for the day which is two (2)&#8239;U.S. Government Securities Business Days preceding the first date of the relevant
interest period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>SOFR Index<SUB>End</SUB></U></I>&rdquo;
is the SOFR Index value for the day which is two (2)&#8239;U.S. Government Securities Business Days preceding the Interest Payment Date
relating to such interest period; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<I><U>d<SUB>c</SUB></U></I>&rdquo;
is the number of calendar days in the applicable Observation Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of determining
Compounded SOFR, &ldquo;<U>SOFR Index</U>&rdquo; means, with respect to any U.S. Government Securities Business Day:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">the SOFR Index published for such U.S.
                                            Government Securities Business Day as such value appears on the Federal Reserve Bank of New
                                            York&rsquo;s Website at 3:00 p.m.&#8239;(New York time) on such U.S. Government Securities
                                            Business Day (the &ldquo;<U>SOFR Index Determination Time</U>&rdquo;); or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">if the SOFR Index specified in (1)&#8239;above
                                            does not so appear, unless both a Benchmark Transition Event and its related Benchmark Replacement
                                            Date have occurred, with respect to SOFR, then Compounded SOFR shall be the rate determined
                                            pursuant to the &ldquo;SOFR Index Unavailability&rdquo; provisions below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Interest Payment
Determination Date</U>&rdquo; is the date that is two (2)&#8239;U.S. Government Securities Business Days before each Interest Payment
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Observation Period</U>&rdquo;
is, in respect of each interest period for the Securities, the period from, and including, the date that is two (2)&#8239;U.S. Government
Securities Business Days preceding the first date in such interest period to, but excluding, the Interest Payment Determination Date
for such interest period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>SOFR</U>&rdquo;
with respect to any day means the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as
the administrator of the benchmark (or a successor administrator), on the Federal Reserve Bank of New York&rsquo;s Website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>U.S. Government
Securities Business Day</U>&rdquo; is any day except for a Saturday, a Sunday or a day on which the Securities Industry and Financial
Markets Association recommends that the fixed income departments of its members be closed for the entire day for purposes of trading
in U.S. government securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt,
the calculation of Compounded SOFR shall exclude the spread of 0.480% per year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything
to the contrary in this Security or the Indenture if the Company or its Designee determines on or prior to the relevant Reference Time
(as defined herein) that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to determining
Compounded SOFR, then the benchmark replacement provisions set forth herein will thereafter apply to all determinations of the rate of
interest payable on the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt,
in accordance with the benchmark replacement provisions, after a Benchmark Transition Event and its related Benchmark Replacement Date
have occurred, the interest rate for each interest period on the Securities of this series will be an annual rate equal to the sum of
the Benchmark Replacement (as defined below) and the spread.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>SOFR Index Unavailability</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If a SOFR Index<SUB>Start</SUB>
or SOFR Index<SUB>End</SUB> is not published on the associated Interest Payment Determination Date and a Benchmark Transition Event and
its related Benchmark Replacement Date have not occurred with respect to SOFR, &ldquo;Compounded SOFR&rdquo; shall be deemed to be equal
to, for the applicable interest period for which such index is not available, the rate of return on a daily compounded interest investment
calculated in accordance with the formula for SOFR Averages, and definitions required for such formula, published on the website of the
Federal Reserve Bank of New York, at https://www.newyorkfed.org/markets/reference-rates/additional-information-about-reference-rates,
or any successor source. For the purposes of this provision, references in the SOFR Averages compounding formula and related definitions
to &ldquo;calculation period&rdquo; shall be replaced with &ldquo;Observation Period&rdquo; and the words &ldquo;that is, 30-, 90-, or
180- calendar days&rdquo; shall be removed. If the daily SOFR (&ldquo;<U>SOFR<SUB>i</SUB></U>&rdquo;) does not so appear for any day,
&ldquo;i&rdquo;, in the Observation Period, SOFR<SUB>i</SUB> for such day &ldquo;i&rdquo; shall be deemed to be SOFR published in respect
of the first preceding U.S. Government Securities Business Day for which SOFR was published on the Federal Reserve Bank of New York&rsquo;s
Website.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><I>Effect of Benchmark Transition Event</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company or its Designee
determines that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred on or prior to the Reference Time
in respect of any determination of the Benchmark on any date, the Benchmark Replacement will replace the then-current Benchmark for all
purposes relating to the Securities in respect of such determination on such date and for all determinations on all subsequent dates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the implementation
of a Benchmark Replacement, the Company (or its Designee) will have the right to make Benchmark Replacement Conforming Changes from time
to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any determination, decision
or election that may be made by the Company (or its Designee) pursuant to this Security, including any determination with respect to
tenor, rate or adjustment or of the occurrence or nonoccurrence of an event, circumstance or date and any decision to take or refrain
from taking any action or any selection, will be conclusive and binding absent manifest error, will be made in the Company&rsquo;s (or
its Designee&rsquo;s) sole discretion, and, notwithstanding anything to the contrary in this Security or the Indenture, shall become
effective without consent from the Holders of the Securities or any other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Benchmark</U>&rdquo;
means, initially, Compounded SOFR; provided that, if a Benchmark Transition Event and its related Benchmark Replacement Date shall have
occurred with respect to Compounded SOFR or the then-current Benchmark, then &ldquo;Benchmark&rdquo; shall mean the applicable Benchmark
Replacement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Benchmark Replacement</U>&rdquo;
means the first alternative set forth in the order below that can be determined by the Company (or its Designee) as of the Benchmark
Replacement Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">the sum of: (a)&#8239;the alternate rate
                                            of interest that has been selected or recommended by the Relevant Governmental Body as the
                                            replacement for the then-current Benchmark and (b)&#8239;the Benchmark Replacement Adjustment;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">the sum of: (a)&#8239;the ISDA Fallback
                                            Rate and (b)&#8239;the Benchmark Replacement Adjustment; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">the sum of: (a)&#8239;the alternate rate
                                            of interest that has been selected by the Company (or its Designee) as the replacement for
                                            the then-current Benchmark giving due consideration to any industry-accepted rate of interest
                                            as a replacement for the then-current Benchmark for U.S. dollar-denominated floating rate
                                            notes at such time and (b)&#8239;the Benchmark Replacement Adjustment.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Benchmark Replacement
Adjustment</U>&rdquo; means the first alternative set forth in the order below that can be determined by the Company (or its Designee)
as of the Benchmark Replacement Date:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">the spread adjustment (which may be
                                            a positive or negative value or zero), or method for calculating or determining such spread
                                            adjustment, that has been selected or recommended by the Relevant Governmental Body for the
                                            applicable Unadjusted Benchmark Replacement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">if the applicable Unadjusted Benchmark
                                            Replacement is equivalent to the ISDA Fallback Rate, then the ISDA Fallback Adjustment; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">the spread adjustment (which may be
                                            a positive or negative value or zero) that has been selected by the Company (or its Designee)
                                            giving due consideration to any industry-accepted spread adjustment, or method for calculating
                                            or determining such spread adjustment, for the replacement of the then-current Benchmark
                                            with the applicable Unadjusted Benchmark Replacement for U.S. dollar-denominated floating
                                            rate notes at such time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Benchmark Replacement
Conforming Changes</U>&rdquo; means, with respect to any Benchmark Replacement, any technical, administrative or operational changes
(including changes to the definitions of &ldquo;interest period&rdquo; and &ldquo;Observation Period,&rdquo; the timing and frequency
of determining rates and making payments of interest, the rounding of amounts or tenors and other administrative matters) that the Company
(or its Designee) decides may be appropriate to reflect the adoption of such Benchmark Replacement in a manner substantially consistent
with market practice (or, if the Company (or its Designee) decides that adoption of any portion of such market practice is not administratively
feasible or if the Company (or its Designee) determines that no market practice for use of the Benchmark Replacement exists, in such
other manner as the Company (or its Designee) determines is reasonably necessary).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Benchmark Replacement
Date</U>&rdquo; means the earliest to occur of the following events with respect to the then-current Benchmark:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">in the case of clause (1)&#8239;or (2)&#8239;of
                                            the definition of &ldquo;Benchmark Transition Event,&rdquo; the later of (a)&#8239;the date
                                            of the public statement or publication of information referenced therein and (b)&#8239;the
                                            date on which the administrator of the Benchmark permanently or indefinitely ceases to provide
                                            the Benchmark; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">in the case of clause (3)&#8239;of the
                                            definition of &ldquo;Benchmark Transition Event,&rdquo; the date of the public statement
                                            or publication of information referenced therein.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt,
if the event giving rise to the Benchmark Replacement Date occurs on the same day as, but earlier than, the Reference Time in respect
of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt,
for purposes of the definitions of Benchmark Replacement Date and Benchmark Transition Event, references to Benchmark also include any
reference rate underlying such Benchmark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Benchmark Transition
Even</U>t&rdquo; means the occurrence of one or more of the following events with respect to the then-current Benchmark:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">a public statement or publication of
                                            information by or on behalf of the administrator of the Benchmark announcing that such administrator
                                            has ceased or will cease to provide the Benchmark, permanently or indefinitely; <I>provided</I>
                                            that, at the time of such statement or publication, there is no successor administrator that
                                            will continue to provide the Benchmark;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">a public statement or publication of
                                            information by the regulatory supervisor for the administrator of the Benchmark, the central
                                            bank for the currency of the Benchmark, an insolvency official with jurisdiction over the
                                            administrator for the Benchmark, a resolution authority with jurisdiction over the administrator
                                            for the Benchmark or a court or an entity with similar insolvency or resolution authority
                                            over the administrator for the Benchmark, which states that the administrator of the Benchmark
                                            has ceased or will cease to provide the Benchmark permanently or indefinitely; <I>provided</I>
                                            that, at the time of such statement or publication, there is no successor administrator that
                                            will continue to provide the Benchmark; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">a public statement or publication of
                                            information by the regulatory supervisor for the administrator of the Benchmark announcing
                                            that the Benchmark is no longer representative.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>ISDA Definitions</U>&rdquo;
means the 2006 ISDA Definitions published by the International Swaps and Derivatives Association,&#8239;Inc. or any successor thereto,
as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time
to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>ISDA Fallback Adjustment</U>&rdquo;
means the spread adjustment (which may be a positive or negative value or zero) that would apply for derivatives transactions referencing
the ISDA Definitions to be determined upon the occurrence of an index cessation event with respect to the Benchmark for the applicable
tenor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>ISDA Fallback Rate</U>&rdquo;
means the rate that would apply for derivatives transactions referencing the ISDA Definitions to be effective upon the occurrence of
an index cessation date with respect to the Benchmark for the applicable tenor excluding the applicable ISDA Fallback Adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Reference Time</U>&rdquo;
with respect to any determination of the Benchmark for the Securities of this series means (1)&#8239;if the Benchmark is Compounded SOFR,
the SOFR Index Determination Time and (2)&#8239;if the Benchmark is not Compounded SOFR, the time determined by the Company or its Designee
after giving effect to the Benchmark Replacement Conforming Changes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Relevant Governmental
Body</U>&rdquo; means the Federal Reserve Board and/or the Federal Reserve Bank of New York, or a committee officially endorsed or convened
by the Federal Reserve Board and/or the Federal Reserve Bank of New York or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Unadjusted Benchmark
Replacement</U>&rdquo; means the Benchmark Replacement excluding the Benchmark Replacement Adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;,
2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Executive Vice President<BR>
 Chief Financial Officer</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;,
2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, </TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">[Authorized Officer]</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&#8239;OF ]REVERSE OF SECURITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is one of a
duly authorized issue of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one
or more series under an Indenture, dated as of November&#8239;8, 2012, as it may be supplemented or amended from time to time (herein
called the &ldquo;<U>Indenture</U>&rdquo;), between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
to U.S. Bank National Association, as trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee
under the Indenture), and Supplemental Indenture No.&#8239;12, dated as of March&#8239;4, 2026 (herein called the &ldquo;<U>Supplemental
Indenture</U>&rdquo;), among the Company and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of
the Company, the Trustee and the Holders of the Securities of this series and of the terms upon which the Securities of this series are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, in an initial aggregate
principal amount of $750,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is not redeemable
prior to its maturity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
do not provide for a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply
to the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee
with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series
to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
at the time Outstanding of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture or Supplemental Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security
at the times, place and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like
aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such
transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections&#8239;9.6 or 11.7 of
the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person
in whose name this Security is registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether
or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
which are defined in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Book-Entry
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture and may not be transferred except as a whole by the Depository to a nominee
of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
principal amount of Securities held in (check applicable space) <U>&#8239;&#8239;&#8239;&#8239;&#8239;</U> book-entry or <U>&#8239;&#8239;&#8239;&#8239;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transferor (check one
box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to deliver in exchange for its beneficial interest
                                            in the global Security held by the Depository a Security or Securities in definitive, registered
                                            form of authorized denominations in an aggregate principal amount equal to its beneficial
                                            interest in such global Security (or the portion thereof indicated above); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to exchange or register the transfer of a Security
                                            or Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Date&#8239;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    decrease&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    increase&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-<BR>
    Entry&#8239;Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security&#8239;following<BR>
    such&#8239;decrease&#8239;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&#8239;of<BR>
    authorized<BR>
    signatory&#8239;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert
    assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 35%; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 45%; font-size: 10pt">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*NOTICE: The signature to this assignment must
correspond with the name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change
whatever. Such signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security
Registrar, which requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;)
or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-1-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&#8239;A2</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_002"></A>[Form&#8239;of ]3.775% Senior Notes due 2028</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD><B>No.&#8239;[&bull;]</B></TD>
  <TD STYLE="text-align: right"><B>&#8239;&#8239;&#8239;&#8239;&#8239;$[&bull;]</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y ED7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YED76</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Security
in a global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This global Security is exchangeable for Securities registered in the name of a Person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of
this Security as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another
nominee of the Depository) may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless this Security is presented
by an authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or
payment, and any Security issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in
the name of Cede&#8239;&amp; Co. or such other name as requested by an authorized representative of The Depository Trust Company and any
payment hereon is made to Cede&#8239;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL since&#8239;the registered owner hereof, Cede&#8239;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ABBVIE INC., a corporation
duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term includes any successor
Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises to pay to Cede&#8239;&amp;
Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [&bull;] Dollars ($[&bull;]), or such other
principal sum as may be indicated on the Schedule of Exchanges attached hereto, on March&#8239;3, 2028 and to pay interest thereon from
March&#8239;4, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually
in arrears on March&#8239;3 and September&#8239;3 in each year, commencing September&#8239;3, 2026, at the rate of 3.775% per annum, until
the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for, on any
Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen
(15) calendar days prior to the relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid
or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person
in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series
not less than ten (10)&#8239;days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent
with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be
required by such exchange, all as more fully provided in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal
of (and premium, if any) and any such interest on this Security will be made at the office or agency of the Company maintained for that
purpose in St. Paul, Minnesota, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by (1)&#8239;check
mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (2)&#8239;wire transfer
as directed by the Holder, in immediately available funds to an account maintained by the Depository or its nominee with respect to a
Global Note, and to the Holder or its nominee with respect to a Definitive Note; provided, further, that in the case of a Definitive
Note (1)&#8239;the Holder thereof shall have provided written wiring instructions to the Trustee on or before the related Regular Record
Date and (2)&#8239;if appropriate instructions for any such wire transfer are not received by the related Regular Record Date, then such
payment shall be made by check mailed to the address of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Executive Vice President<BR>
 Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif">as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">[Authorized Officer]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&#8239;OF ]REVERSE OF SECURITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is one of a
duly authorized issue of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one
or more series under an Indenture, dated as of November&#8239;8, 2012, as it may be supplemented or amended from time to time (herein
called the &ldquo;<U>Indenture</U>&rdquo;), between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
to U.S. Bank National Association, as trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee
under the Indenture), and Supplemental Indenture No.&#8239;12, dated as of March&#8239;4, 2026 (herein called the &ldquo;<U>Supplemental
Indenture</U>&rdquo;), among the Company and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of
the Company, the Trustee and the Holders of the Securities of this series and of the terms upon which the Securities of this series are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, in an initial aggregate
principal amount of $1,500,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time and from time
to time, the Company may redeem the Securities of this series at its option, in whole or in part, at a Redemption Price (expressed as
a percentage of principal amount and rounded to three decimal places) equal to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#8239;(a)&#8239;the sum
of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
such Securities matured on the maturity date of the Securities of this series) on a semi-annual basis (assuming a 360-day year consisting
of twelve 30-day months) at the Treasury Rate plus 5 basis points, less (b)&#8239;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#8239;100% of the principal
amount of the Securities of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">plus, in either case, accrued
and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo;
means, with respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined
by the Company in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined
by the Company after 4:15&#8239;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon
the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published
by the Board of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or
any successor designation or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant
maturities &mdash; Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury
Rate, the Company shall select, as applicable: (1)&#8239;the yield for the Treasury constant maturity on H.15 exactly equal to the period
from such Redemption Date to the applicable Maturity date of the Securities of this series (the &ldquo;Remaining Life&rdquo;); or (2)&#8239;if
there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding
to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15
immediately longer than the Remaining Life &mdash; and shall interpolate to the applicable Maturity date of the Securities of this series
on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places; or (3)&#8239;if
there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury
constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or
maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury
constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third New York
Business Day preceding such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New
York Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest
to, the Maturity date of the Securities of this series, as applicable. If there is no United States Treasury security maturing on the
Maturity date of the Securities of this series but there are two or more United States Treasury securities with a maturity date equally
distant from the applicable Maturity date of the Securities of this series, one with a maturity date preceding the Maturity date of the
Securities of this series and one with a maturity date following the Maturity date of the Securities of this series, the Company shall
select the United States Treasury security with a maturity date preceding the Maturity date of the Securities of this series. If there
are two or more United States Treasury securities maturing on the Maturity date of the Securities of this series or two or more United
States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United
States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked
prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the applicable
Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury
security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New
York City time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Securities of this series
of a principal amount of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company
(or another depositary), the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable
depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>New York Business
Day</U>&rdquo; means any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks
are open for business in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
do not provide for a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply
to the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee
with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series
to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
at the time Outstanding of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture or Supplemental Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security
at the times, place and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like
aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such
transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections&#8239;9.6 or 11.7 of
the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person
in whose name this Security is registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether
or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
which are defined in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Book-Entry
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture and may not be transferred except as a whole by the Depository to a nominee
of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
principal amount of Securities held in (check applicable space) <U>&#8239;&#8239;&#8239;&#8239;&#8239;</U> book-entry or <U>&#8239;&#8239;&#8239;&#8239;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transferor (check one
box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Symbol"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to deliver in exchange for its beneficial interest
                                            in the global Security held by the Depository a Security or Securities in definitive, registered
                                            form of authorized denominations in an aggregate principal amount equal to its beneficial
                                            interest in such global Security (or the portion thereof indicated above); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to exchange or register the transfer of a Security
                                            or Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Date&#8239;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    decrease&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    increase&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-<BR>
    Entry&#8239;Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security&#8239;following<BR>
    such&#8239;decrease&#8239;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&#8239;of<BR>
    authorized<BR>
    signatory&#8239;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert
    assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 45%">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*NOTICE: The signature to this assignment must
correspond with the name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change
whatever. Such signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security
Registrar, which requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;)
or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-2-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&#8239;A3</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_003"></A>[Form&#8239;of ]4.125% Senior Notes due 2031</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD><B>No.&#8239;[&bull;]</B></TD>
  <TD STYLE="text-align: right"><B>&#8239;&#8239;&#8239;&#8239;&#8239;$[&bull;]</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EE5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YEE59</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Security
in a global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This global Security is exchangeable for Securities registered in the name of a Person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of
this Security as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another
nominee of the Depository) may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless this Security is presented
by an authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or
payment, and any Security issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in
the name of Cede&#8239;&amp; Co. or such other name as requested by an authorized representative of The Depository Trust Company and any
payment hereon is made to Cede&#8239;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL since&#8239;the registered owner hereof, Cede&#8239;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ABBVIE INC., a corporation
duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term includes any successor
Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises to pay to Cede&#8239;&amp;
Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [&bull;] Dollars ($[&bull;]), or such other
principal sum as may be indicated on the Schedule of Exchanges attached hereto, on March&#8239;15, 2031 and to pay interest thereon from
March&#8239;4, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually
in arrears on March&#8239;15 and September&#8239;15 in each year, commencing September&#8239;15, 2026, at the rate of 4.125% per annum,
until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for,
on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen
(15) calendar days prior to the relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid
or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person
in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series
not less than ten (10)&#8239;days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent
with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be
required by such exchange, all as more fully provided in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal
of (and premium, if any) and any such interest on this Security will be made at the office or agency of the Company maintained for that
purpose in St. Paul, Minnesota, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by (1)&#8239;check
mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (2)&#8239;wire transfer
as directed by the Holder, in immediately available funds to an account maintained by the Depository or its nominee with respect to a
Global Note, and to the Holder or its nominee with respect to a Definitive Note; provided, further, that in the case of a Definitive
Note (1)&#8239;the Holder thereof shall have provided written wiring instructions to the Trustee on or before the related Regular Record
Date and (2)&#8239;if appropriate instructions for any such wire transfer are not received by the related Regular Record Date, then such
payment shall be made by check mailed to the address of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Executive Vice President <BR>
Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">[Authorized Officer]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&#8239;OF ]REVERSE OF SECURITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is one of a
duly authorized issue of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one
or more series under an Indenture, dated as of November&#8239;8, 2012, as it may be supplemented or amended from time to time (herein
called the &ldquo;<U>Indenture</U>&rdquo;), between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
to U.S. Bank National Association, as trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee
under the Indenture), and Supplemental Indenture No.&#8239;12, dated as of March&#8239;4, 2026 (herein called the &ldquo;<U>Supplemental
Indenture</U>&rdquo;), among the Company and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of
the Company, the Trustee and the Holders of the Securities of this series and of the terms upon which the Securities of this series are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, in an initial aggregate
principal amount of $1,250,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time prior to the
Par Call Date (as defined below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time
and from time to time, at a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal
to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#8239;(a)&#8239;the sum
of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
such Securities matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at
the Treasury Rate plus 10 basis points, less (b)&#8239;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#8239;100% of the principal
amount of the Securities of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">plus, in either case, accrued
and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On or after the Par Call
Date, the Company may redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price
equal to 100% of the principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the
Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Par Call Date</U>&rdquo;
means February&#8239;15, 2031 (the date that is one (1)&#8239;month prior to the maturity date of the Securities of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo;
means, with respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined
by the Company in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined
by the Company after 4:15&#8239;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon
the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published
by the Board of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or
any successor designation or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant
maturities &mdash; Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury
Rate, the Company shall select, as applicable: (1)&#8239;the yield for the Treasury constant maturity on H.15 exactly equal to the period
from such Redemption Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&#8239;if there is no such Treasury
constant maturity on H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant
maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than
the Remaining Life &mdash; and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of
days) using such yields and rounding the result to three decimal places; or (3)&#8239;if there is no such Treasury constant maturity on
H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third New York
Business Day preceding such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New
York Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest
to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two
or more United States Treasury securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity
date preceding the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States
Treasury security with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing
on the Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall
select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to
par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the applicable
Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury
security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New
York City time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Securities of this series
of a principal amount of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company
(or another depositary), the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable
depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>New York Business
Day</U>&rdquo; means any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks
are open for business in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
do not provide for a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply
to the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee
with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series
to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
at the time Outstanding of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture or Supplemental Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security
at the times, place and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like
aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such
transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections&#8239;9.6 or 11.7 of
the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person
in whose name this Security is registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether
or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
which are defined in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Book-Entry
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture and may not be transferred except as a whole by the Depository to a nominee
of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
principal amount of Securities held in (check applicable space) <U>&#8239;&#8239;&#8239;&#8239;&#8239;</U> book-entry or <U>&#8239;&#8239;&#8239;&#8239;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transferor (check one
box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to deliver in exchange for its beneficial interest
                                            in the global Security held by the Depository a Security or Securities in definitive, registered
                                            form of authorized denominations in an aggregate principal amount equal to its beneficial
                                            interest in such global Security (or the portion thereof indicated above); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to exchange or register the transfer of a Security
                                            or Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Date&#8239;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    decrease&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    increase&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-<BR>
    Entry&#8239;Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security&#8239;following<BR>
    such&#8239;decrease&#8239;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&#8239;of<BR>
    authorized<BR>
    signatory&#8239;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert
    assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 45%">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*NOTICE: The signature to this assignment must
correspond with the name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change
whatever. Such signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security
Registrar, which requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;)
or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-3-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&#8239;A4</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_004"></A>[Form&#8239;of ]4.400% Senior Notes due 2033</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD><B>No.&#8239;[&bull;]</B></TD>
  <TD STYLE="text-align: right"><B>&#8239;&#8239;&#8239;&#8239;&#8239;$[&bull;]</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EF2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YEF25</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Security
in a global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This global Security is exchangeable for Securities registered in the name of a Person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of
this Security as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another
nominee of the Depository) may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless this Security is presented
by an authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or
payment, and any Security issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in
the name of Cede&#8239;&amp; Co. or such other name as requested by an authorized representative of The Depository Trust Company and any
payment hereon is made to Cede&#8239;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL since&#8239;the registered owner hereof, Cede&#8239;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ABBVIE INC., a corporation
duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term includes any successor
Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises to pay to Cede&#8239;&amp;
Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [&bull;] Dollars ($[&bull;]), or such other
principal sum as may be indicated on the Schedule of Exchanges attached hereto, on March&#8239;15, 2033 and to pay interest thereon from
March&#8239;4, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually
in arrears on March&#8239;15 and September&#8239;15 in each year, commencing September&#8239;15, 2026, at the rate of 4.400% per annum,
until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for,
on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen
(15) calendar days prior to the relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid
or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person
in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series
not less than ten (10)&#8239;days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent
with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be
required by such exchange, all as more fully provided in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal
of (and premium, if any) and any such interest on this Security will be made at the office or agency of the Company maintained for that
purpose in St. Paul, Minnesota, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by (1)&#8239;check
mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (2)&#8239;wire transfer
as directed by the Holder, in immediately available funds to an account maintained by the Depository or its nominee with respect to a
Global Note, and to the Holder or its nominee with respect to a Definitive Note; provided, further, that in the case of a Definitive
Note (1)&#8239;the Holder thereof shall have provided written wiring instructions to the Trustee on or before the related Regular Record
Date and (2)&#8239;if appropriate instructions for any such wire transfer are not received by the related Regular Record Date, then such
payment shall be made by check mailed to the address of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Executive Vice President<BR>
 Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">[Authorized Officer]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&#8239;OF ]REVERSE OF SECURITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is one of a
duly authorized issue of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one
or more series under an Indenture, dated as of November&#8239;8, 2012, as it may be supplemented or amended from time to time (herein
called the &ldquo;<U>Indenture</U>&rdquo;), between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
to U.S. Bank National Association, as trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee
under the Indenture), and Supplemental Indenture No.&#8239;12, dated as of March&#8239;4, 2026 (herein called the &ldquo;<U>Supplemental
Indenture</U>&rdquo;), among the Company and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of
the Company, the Trustee and the Holders of the Securities of this series and of the terms upon which the Securities of this series are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, in an initial aggregate
principal amount of $1,250,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time prior to the
Par Call Date (as defined below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time
and from time to time, at a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal
to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#8239;(a)&#8239;the sum
of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
such Securities matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at
the Treasury Rate plus 10 basis points, less (b)&#8239;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#8239;100% of the principal
amount of the Securities of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">plus, in either case, accrued
and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On or after the Par Call
Date, the Company may redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price
equal to 100% of the principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the
Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Par Call Date</U>&rdquo;
means January&#8239;15, 2033 (the date that is two (2)&#8239;months prior to the maturity date of the Securities of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo;
means, with respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined
by the Company in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined
by the Company after 4:15&#8239;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon
the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published
by the Board of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or
any successor designation or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant
maturities &mdash; Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury
Rate, the Company shall select, as applicable: (1)&#8239;the yield for the Treasury constant maturity on H.15 exactly equal to the period
from such Redemption Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&#8239;if there is no such Treasury
constant maturity on H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant
maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than
the Remaining Life &mdash; and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of
days) using such yields and rounding the result to three decimal places; or (3)&#8239;if there is no such Treasury constant maturity on
H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third New York
Business Day preceding such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New
York Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest
to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two
or more United States Treasury securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity
date preceding the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States
Treasury security with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing
on the Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall
select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to
par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the applicable
Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury
security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New
York City time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Securities of this series
of a principal amount of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company
(or another depositary), the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable
depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>New York Business
Day</U>&rdquo; means any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks
are open for business in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
do not provide for a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply
to the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee
with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series
to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
at the time Outstanding of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture or Supplemental Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security
at the times, place and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like
aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such
transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections&#8239;9.6 or 11.7 of
the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person
in whose name this Security is registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether
or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
which are defined in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Book-Entry
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture and may not be transferred except as a whole by the Depository to a nominee
of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository.&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
principal amount of Securities held in (check applicable space) <U>&#8239;&#8239;&#8239;&#8239;&#8239;</U> book-entry or <U>&#8239;&#8239;&#8239;&#8239;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transferor (check one
box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to deliver in exchange for its beneficial interest
                                            in the global Security held by the Depository a Security or Securities in definitive, registered
                                            form of authorized denominations in an aggregate principal amount equal to its beneficial
                                            interest in such global Security (or the portion thereof indicated above); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to exchange or register the transfer of a Security
                                            or Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Date&#8239;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    decrease&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    increase&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-<BR>
    Entry&#8239;Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security&#8239;following<BR>
    such&#8239;decrease&#8239;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&#8239;of<BR>
    authorized<BR>
    signatory&#8239;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert
    assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 45%">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*NOTICE: The signature to this assignment must
correspond with the name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change
whatever. Such signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security
Registrar, which requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;)
or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-4-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&#8239;A5</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_005"></A>[Form&#8239;of ]4.750% Senior Notes due 2036</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD><B>No.&#8239;[&bull;]</B></TD>
  <TD STYLE="text-align: right"><B>&#8239;&#8239;&#8239;&#8239;&#8239;$[&bull;]</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EG0</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YEG08</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Security
in a global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This global Security is exchangeable for Securities registered in the name of a Person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of
this Security as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another
nominee of the Depository) may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless this Security is presented
by an authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or
payment, and any Security issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in
the name of Cede&#8239;&amp; Co. or such other name as requested by an authorized representative of The Depository Trust Company and any
payment hereon is made to Cede&#8239;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL since&#8239;the registered owner hereof, Cede&#8239;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ABBVIE INC., a corporation
duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term includes any successor
Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises to pay to Cede&#8239;&amp;
Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [&bull;] Dollars ($[&bull;]), or such other
principal sum as may be indicated on the Schedule of Exchanges attached hereto, on March&#8239;15, 2036 and to pay interest thereon from
March&#8239;4, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually
in arrears on March&#8239;15 and September&#8239;15 in each year, commencing September&#8239;15, 2026, at the rate of 4.750% per annum,
until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for,
on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen
(15) calendar days prior to the relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid
or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person
in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series
not less than ten (10)&#8239;days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent
with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be
required by such exchange, all as more fully provided in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal
of (and premium, if any) and any such interest on this Security will be made at the office or agency of the Company maintained for that
purpose in St. Paul, Minnesota, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by (1)&#8239;check
mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (2)&#8239;wire transfer
as directed by the Holder, in immediately available funds to an account maintained by the Depository or its nominee with respect to a
Global Note, and to the Holder or its nominee with respect to a Definitive Note; provided, further, that in the case of a Definitive
Note (1)&#8239;the Holder thereof shall have provided written wiring instructions to the Trustee on or before the related Regular Record
Date and (2)&#8239;if appropriate instructions for any such wire transfer are not received by the related Regular Record Date, then such
payment shall be made by check mailed to the address of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Executive Vice President<BR>
 Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">[Authorized Officer]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&#8239;OF ]REVERSE OF SECURITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is one of a
duly authorized issue of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one
or more series under an Indenture, dated as of November&#8239;8, 2012, as it may be supplemented or amended from time to time (herein
called the &ldquo;<U>Indenture</U>&rdquo;), between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
to U.S. Bank National Association, as trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee
under the Indenture), and Supplemental Indenture No.&#8239;12, dated as of March&#8239;4, 2026 (herein called the &ldquo;<U>Supplemental
Indenture</U>&rdquo;), among the Company and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of
the Company, the Trustee and the Holders of the Securities of this series and of the terms upon which the Securities of this series are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, in an initial aggregate
principal amount of $1,500,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time prior to the
Par Call Date (as defined below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time
and from time to time, at a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal
to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#8239;(a)&#8239;the sum
of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
such Securities matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at
the Treasury Rate plus 15 basis points, less (b)&#8239;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#8239;100% of the principal
amount of the Securities of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">plus, in either case, accrued
and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On or after the Par Call
Date, the Company may redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price
equal to 100% of the principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the
Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Par Call Date</U>&rdquo;
means December&#8239;15, 2035 (the date that is three (3)&#8239;months prior to the maturity date of the Securities of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo;
means, with respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined
by the Company in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined
by the Company after 4:15&#8239;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon
the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published
by the Board of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or
any successor designation or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant
maturities &mdash; Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury
Rate, the Company shall select, as applicable: (1)&#8239;the yield for the Treasury constant maturity on H.15 exactly equal to the period
from such Redemption Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&#8239;if there is no such Treasury
constant maturity on H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant
maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than
the Remaining Life &mdash; and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of
days) using such yields and rounding the result to three decimal places; or (3)&#8239;if there is no such Treasury constant maturity on
H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third New York
Business Day preceding such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New
York Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest
to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two
or more United States Treasury securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity
date preceding the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States
Treasury security with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing
on the Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall
select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to
par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the applicable
Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury
security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New
York City time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Securities of this series
of a principal amount of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company
(or another depositary), the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable
depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>New York Business
Day</U>&rdquo; means any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks
are open for business in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
do not provide for a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply
to the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee
with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series
to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
at the time Outstanding of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture or Supplemental Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security
at the times, place and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like
aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such
transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections&#8239;9.6 or 11.7 of
the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person
in whose name this Security is registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether
or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
which are defined in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Book-Entry
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture and may not be transferred except as a whole by the Depository to a nominee
of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
principal amount of Securities held in (check applicable space) <U>&#8239;&#8239;&#8239;&#8239;&#8239;</U> book-entry or <U>&#8239;&#8239;&#8239;&#8239;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transferor (check one
box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to deliver in exchange for its beneficial interest
                                            in the global Security held by the Depository a Security or Securities in definitive, registered
                                            form of authorized denominations in an aggregate principal amount equal to its beneficial
                                            interest in such global Security (or the portion thereof indicated above); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to exchange or register the transfer of a Security
                                            or Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Date&#8239;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    decrease&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    increase&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-<BR>
    Entry&#8239;Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security&#8239;following<BR>
    such&#8239;decrease&#8239;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&#8239;of<BR>
    authorized<BR>
    signatory&#8239;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert
    assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 45%">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*NOTICE: The signature to this assignment must
correspond with the name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change
whatever. Such signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security
Registrar, which requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;)
or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-5-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&#8239;A6</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_006"></A>[Form&#8239;of ]5.550% Senior Notes due 2056</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD><B>No.&#8239;[&bull;]</B></TD>
  <TD STYLE="text-align: right"><B>&#8239;&#8239;&#8239;&#8239;&#8239;$[&bull;]</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EH8</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YEH80</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Security
in a global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This global Security is exchangeable for Securities registered in the name of a Person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of
this Security as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another
nominee of the Depository) may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless this Security is presented
by an authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or
payment, and any Security issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in
the name of Cede&#8239;&amp; Co. or such other name as requested by an authorized representative of The Depository Trust Company and any
payment hereon is made to Cede&#8239;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL since&#8239;the registered owner hereof, Cede&#8239;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ABBVIE INC., a corporation
duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term includes any successor
Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises to pay to Cede&#8239;&amp;
Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [&bull;] Dollars ($[&bull;]), or such other
principal sum as may be indicated on the Schedule of Exchanges attached hereto, on March&#8239;15, 2056 and to pay interest thereon from
March&#8239;4, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually
in arrears on March&#8239;15 and September&#8239;15 in each year, commencing September&#8239;15, 2026, at the rate of 5.550% per annum,
until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for,
on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen
(15) calendar days prior to the relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid
or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person
in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series
not less than ten (10)&#8239;days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent
with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be
required by such exchange, all as more fully provided in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 70; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal
of (and premium, if any) and any such interest on this Security will be made at the office or agency of the Company maintained for that
purpose in St. Paul, Minnesota, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by (1)&#8239;check
mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (2)&#8239;wire transfer
as directed by the Holder, in immediately available funds to an account maintained by the Depository or its nominee with respect to a
Global Note, and to the Holder or its nominee with respect to a Definitive Note; provided, further, that in the case of a Definitive
Note (1)&#8239;the Holder thereof shall have provided written wiring instructions to the Trustee on or before the related Regular Record
Date and (2)&#8239;if appropriate instructions for any such wire transfer are not received by the related Regular Record Date, then such
payment shall be made by check mailed to the address of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Executive Vice President <BR>
Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">[Authorized Officer]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[FORM&#8239;OF ]REVERSE OF SECURITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is one of a
duly authorized issue of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one
or more series under an Indenture, dated as of November&#8239;8, 2012, as it may be supplemented or amended from time to time (herein
called the &ldquo;<U>Indenture</U>&rdquo;), between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
to U.S. Bank National Association, as trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee
under the Indenture), and Supplemental Indenture No.&#8239;12, dated as of March&#8239;4, 2026 (herein called the &ldquo;<U>Supplemental
Indenture</U>&rdquo;), among the Company and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of
the Company, the Trustee and the Holders of the Securities of this series and of the terms upon which the Securities of this series are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, in an initial aggregate
principal amount of $1,250,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time prior to the
Par Call Date (as defined below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time
and from time to time, at a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal
to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#8239;(a)&#8239;the sum
of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
such Securities matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at
the Treasury Rate plus 15 basis points, less (b)&#8239;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#8239;100% of the principal
amount of the Securities of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">plus, in either case, accrued
and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On or after the Par Call
Date, the Company may redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price
equal to 100% of the principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the
Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Par Call Date</U>&rdquo;
means September&#8239;15, 2055 (the date that is six (6)&#8239;months prior to the maturity date of the Securities of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo;
means, with respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined
by the Company in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined
by the Company after 4:15&#8239;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon
the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published
by the Board of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or
any successor designation or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant
maturities &mdash; Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury
Rate, the Company shall select, as applicable: (1)&#8239;the yield for the Treasury constant maturity on H.15 exactly equal to the period
from such Redemption Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&#8239;if there is no such Treasury
constant maturity on H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant
maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than
the Remaining Life &mdash; and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of
days) using such yields and rounding the result to three decimal places; or (3)&#8239;if there is no such Treasury constant maturity on
H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third New York
Business Day preceding such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New
York Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest
to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two
or more United States Treasury securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity
date preceding the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States
Treasury security with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing
on the Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall
select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to
par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the applicable
Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury
security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New
York City time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Securities of this series
of a principal amount of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company
(or another depositary), the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable
depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>New York Business
Day</U>&rdquo; means any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks
are open for business in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
do not provide for a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply
to the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee
with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series
to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
at the time Outstanding of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture or Supplemental Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security
at the times, place and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like
aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such
transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections&#8239;9.6 or 11.7 of
the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person
in whose name this Security is registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether
or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
which are defined in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Book-Entry
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture and may not be transferred except as a whole by the Depository to a nominee
of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
principal amount of Securities held in (check applicable space) <U>&#8239;&#8239;&#8239;&#8239;&#8239;</U> book-entry or <U>&#8239;&#8239;&#8239;&#8239;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transferor (check one
box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings; color: #0070c0"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to deliver in exchange for its beneficial interest
                                            in the global Security held by the Depository a Security or Securities in definitive, registered
                                            form of authorized denominations in an aggregate principal amount equal to its beneficial
                                            interest in such global Security (or the portion thereof indicated above); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings; color: #0070c0"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to exchange or register the transfer of a Security
                                            or Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Date&#8239;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    decrease&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    increase&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-<BR>
    Entry&#8239;Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security&#8239;following<BR>
    such&#8239;decrease&#8239;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&#8239;of<BR>
    authorized<BR>
    signatory&#8239;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert
    assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 45%">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*NOTICE: The signature to this assignment must
correspond with the name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change
whatever. Such signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security
Registrar, which requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;)
or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-6-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT&#8239;A7</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ABBVIE INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_007"></A>[Form&#8239;of ]5.650% Senior Notes due 2066</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD><B>No.&#8239;[&bull;]</B></TD>
  <TD STYLE="text-align: right"><B>&#8239;&#8239;&#8239;&#8239;&#8239;$[&bull;]</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CUSIP No: 00287Y EJ4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ISIN No: US00287YEJ47</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Security
in a global form within the meaning of the Indenture hereinafter referred to and is registered in the name of the Depository or a nominee
of the Depository. This global Security is exchangeable for Securities registered in the name of a Person other than the Depository or
its nominee only in the limited circumstances described in the Indenture, and no transfer of this Security (other than a transfer of
this Security as a whole by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another
nominee of the Depository) may be registered except in such limited circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless this Security is presented
by an authorized representative of The Depository Trust Company to the issuer or its agent for registration of transfer, exchange or
payment, and any Security issued upon registration of transfer of, or in exchange for, or in lieu of, this Security is registered in
the name of Cede&#8239;&amp; Co. or such other name as requested by an authorized representative of The Depository Trust Company and any
payment hereon is made to Cede&#8239;&amp; Co., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL since&#8239;the registered owner hereof, Cede&#8239;&amp; Co., has an interest herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ABBVIE INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ABBVIE INC., a corporation
duly organized and existing under the laws of Delaware (herein called the &ldquo;<U>Company</U>,&rdquo; which term includes any successor
Person under the Indenture and Supplemental Indenture hereinafter referred to), for value received, hereby promises to pay to Cede&#8239;&amp;
Co., as nominee for The Depository Trust Company, or registered assigns, the principal sum of [&bull;] Dollars ($[&bull;]), or such other
principal sum as may be indicated on the Schedule of Exchanges attached hereto, on March&#8239;15, 2066 and to pay interest thereon from
March&#8239;4, 2026 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, semi-annually
in arrears on March&#8239;15 and September&#8239;15 in each year, commencing September&#8239;15, 2026, at the rate of 5.650% per annum,
until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for,
on any Interest Payment Date will, as provided in such Indenture, be paid to the Person in whose name this Security (or one or more Predecessor
Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be the date that is fifteen
(15) calendar days prior to the relevant Interest Payment Date (whether or not a Business Day). Any such interest not so punctually paid
or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person
in whose name this Security (or one or more Predecessor Securities) is registered at the close of business on a Special Record Date for
the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series
not less than ten (10)&#8239;days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent
with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be
required by such exchange, all as more fully provided in said Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 81; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Payment of the principal
of (and premium, if any) and any such interest on this Security will be made at the office or agency of the Company maintained for that
purpose in St. Paul, Minnesota, in such coin or currency of the United States of America as at the time of payment is legal tender for
payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by (1)&#8239;check
mailed to the address of the Person entitled thereto as such address shall appear in the Security Register or (2)&#8239;wire transfer
as directed by the Holder, in immediately available funds to an account maintained by the Depository or its nominee with respect to a
Global Note, and to the Holder or its nominee with respect to a Definitive Note; provided, further, that in the case of a Definitive
Note (1)&#8239;the Holder thereof shall have provided written wiring instructions to the Trustee on or before the related Regular Record
Date and (2)&#8239;if appropriate instructions for any such wire transfer are not received by the related Regular Record Date, then such
payment shall be made by check mailed to the address of the Holder specified in the Security Register.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference is hereby made
to the further provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the
same effect as if set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless the certificate of
authentication hereon has been executed by the Trustee referred to herein by manual signature, this Security shall not be entitled to
any benefit under the Indenture or be valid or obligatory for any purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, the Company has caused this
instrument to be duly executed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">ABBVIE INC.</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt; width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%">Scott T. Reents</TD></TR>
  <TR STYLE="font-size: 10pt; vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> Executive Vice President <BR>
Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRUSTEE&rsquo;S CERTIFICATE OF AUTHENTICATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This is one of the Securities of the series designated
therein referred to in the within-mentioned Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: March&#8239;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION,</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.125in">as Trustee</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 4%">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">Name:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 41%"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Title:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#8239;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">[Authorized Officer]</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>[FORM&#8239;OF ]REVERSE
OF SECURITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is one of a
duly authorized issue of securities of the Company (herein called the &ldquo;<U>Securities</U>&rdquo;), issued and to be issued in one
or more series under an Indenture, dated as of November&#8239;8, 2012, as it may be supplemented or amended from time to time (herein
called the &ldquo;<U>Indenture</U>&rdquo;), between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
to U.S. Bank National Association, as trustee (herein called the &ldquo;<U>Trustee</U>,&rdquo; which term includes any successor trustee
under the Indenture), and Supplemental Indenture No.&#8239;12, dated as of March&#8239;4, 2026 (herein called the &ldquo;<U>Supplemental
Indenture</U>&rdquo;), among the Company and the Trustee, to which Indenture, Supplemental Indenture and all indentures supplemental
thereto reference is hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of
the Company, the Trustee and the Holders of the Securities of this series and of the terms upon which the Securities of this series are,
and are to be, authenticated and delivered. This Security is one of the series designated on the face hereof, in an initial aggregate
principal amount of $500,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At any time prior to the
Par Call Date (as defined below), the Company may redeem the Securities of this series at its option, in whole or in part, at any time
and from time to time, at a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal
to the greater of:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&#8239;(a)&#8239;the sum
of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming
such Securities matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at
the Treasury Rate plus 15 basis points, less (b)&#8239;interest accrued to the date of redemption, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&#8239;100% of the principal
amount of the Securities of this series to be redeemed,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">plus, in either case, accrued
and unpaid interest thereon to the Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On or after the Par Call
Date, the Company may redeem the Securities of this series, in whole or in part, at any time and from time to time, at a Redemption Price
equal to 100% of the principal amount of the Securities of this series being redeemed plus accrued and unpaid interest thereon to the
Redemption Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Par Call Date</U>&rdquo;
means September&#8239;15, 2065 (the date that is six (6)&#8239;months prior to the maturity date of the Securities of this series).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Treasury Rate</U>&rdquo;
means, with respect to any Redemption Date for Securities of this series, the yield applicable to this series of Securities determined
by the Company in accordance with the following two paragraphs. The Treasury Rate applicable to this series of Securities shall be determined
by the Company after 4:15&#8239;p.m., New York City time (or after such time as yields on U.S. government securities are posted daily
by the Board of Governors of the Federal Reserve System), on the third New York Business Day preceding such Redemption Date based upon
the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published
by the Board of Governors of the Federal Reserve System designated as &ldquo;Selected Interest Rates (Daily) &mdash; H.15&rdquo; (or
any successor designation or publication) (&ldquo;H.15&rdquo;) under the caption &ldquo;U.S. government securities &mdash; Treasury constant
maturities &mdash; Nominal&rdquo; (or any successor caption or heading) (&ldquo;H.15 TCM&rdquo;). In determining the applicable Treasury
Rate, the Company shall select, as applicable: (1)&#8239;the yield for the Treasury constant maturity on H.15 exactly equal to the period
from such Redemption Date to the applicable Par Call Date (the &ldquo;Remaining Life&rdquo;); or (2)&#8239;if there is no such Treasury
constant maturity on H.15 exactly equal to the Remaining Life, the two yields &mdash; one yield corresponding to the Treasury constant
maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than
the Remaining Life &mdash; and shall interpolate to the applicable Par Call Date on a straight-line basis (using the actual number of
days) using such yields and rounding the result to three decimal places; or (3)&#8239;if there is no such Treasury constant maturity on
H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining
Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity
date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from such redemption date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If on the third New York
Business Day preceding such Redemption Date, H.15 TCM is no longer published, the Company shall calculate the applicable Treasury Rate
based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second New
York Business Day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest
to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two
or more United States Treasury securities with a maturity date equally distant from the applicable Par Call Date, one with a maturity
date preceding the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States
Treasury security with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing
on the Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall
select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to
par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In determining the applicable
Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury
security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11:00 a.m., New
York City time, of such United States Treasury security, and rounded to three decimal places.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&rsquo;s actions
and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent manifest error.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No Securities of this series
of a principal amount of $2,000 or less will be redeemed in part. For so long as the Securities are held by The Depository Trust Company
(or another depositary), the redemption of the Securities shall be done in accordance with the policies and procedures of the applicable
depositary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>New York Business
Day</U>&rdquo; means any calendar day that is not a Saturday, Sunday or legal holiday in New York, New York and on which commercial banks
are open for business in New York, New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
do not provide for a sinking fund.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an Event of Default with
respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due
and payable in the manner and with the effect provided in the Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture contains provisions
for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and Events of Default with respect
to this Security, in each case upon compliance with certain conditions set forth therein. Sections 13.2 and 13.3 of the Indenture apply
to the Securities of this series.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the
rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee
with the consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding of each series
to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities
at the time Outstanding of any series, on behalf of the Holders of all Securities of such series, to waive compliance by the Company
with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver
by the Holder of this Security shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any
Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent
or waiver is made upon this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No reference herein to the
Indenture or Supplemental Indenture and no provision of this Security or of the Indenture or Supplemental Indenture shall alter or impair
the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security
at the times, place and rate, and in the coin or currency, herein prescribed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As provided in the Indenture
and subject to certain limitations therein set forth, the transfer of this Security is registerable in the Security Register, upon surrender
of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium
and interest on this Security are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory
to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon
one or more new Securities of this series and of like tenor, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Securities of this series
are issuable only in registered form without coupons in denominations of $2,000 and any integral multiple of $1,000 in excess thereof.
As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like
aggregate principal amount of Securities of this series and of like tenor of a different authorized denomination, as requested by the
Holder surrendering the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No service charge shall be
made for any registration of transfer or exchange of the Notes, but the Company or the Security Registrar may require payment of a sum
sufficient to cover any transfer tax, assessments, or similar governmental charge payable in connection therewith (other than any such
transfer taxes, assessments or similar governmental charge payable upon exchange or transfer pursuant to Sections&#8239;9.6 or 11.7 of
the Indenture).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Prior to due presentment
of this Security for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee will treat the Person
in whose name this Security is registered as the owner hereof for the purpose of receiving payments and for all other purposes, whether
or not this Security be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All terms used in this Security
which are defined in the Indenture and Supplemental Indenture shall have the meanings assigned to them in the Indenture and Supplemental
Indenture.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS SECURITY SHALL BE GOVERNED
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Security is a Book-Entry
Security within the meaning of the Indenture hereinafter referred to and is registered in the name of a Depository or a nominee of a
Depository. This Security is exchangeable for Securities registered in the name of a person other than the Depository or its nominee
only in the limited circumstances described in the Indenture and may not be transferred except as a whole by the Depository to a nominee
of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATE TO BE DELIVERED UPON EXCHANGE<BR>
OR REGISTRATION OF TRANSFER OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Certificate relates to $<U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
principal amount of Securities held in (check applicable space) <U>&#8239;&#8239;&#8239;&#8239;&#8239;</U> book-entry or <U>&#8239;&#8239;&#8239;&#8239;</U>
definitive form by <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
(the &ldquo;<U>Transferor</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transferor (check one
box below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings; color: #0070c0"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to deliver in exchange for its beneficial interest
                                            in the global Security held by the Depository a Security or Securities in definitive, registered
                                            form of authorized denominations in an aggregate principal amount equal to its beneficial
                                            interest in such global Security (or the portion thereof indicated above); or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Wingdings">&#168;</FONT><FONT STYLE="font-family: Wingdings; color: #0070c0"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">has
                                            requested the Trustee by written order to exchange or register the transfer of a Security
                                            or Securities.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD STYLE="text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[INSERT
    NAME OF TRANSFEROR]</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.375in; width: 10%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 40%">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE OF EXCHANGES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following exchanges, redemptions or purchases
of a part of this Book-Entry Security have been made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Date&#8239;of<BR>
    Exchange/<BR>
    Redemption/<BR>
    Repurchase</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    decrease&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Amount&#8239;of<BR>
    increase&#8239;in<BR>
    Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-<BR>
    Entry&#8239;Security</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 19%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Principal&#8239;Amount<BR>
    of&#8239;this&#8239;Book-Entry<BR>
    Security&#8239;following<BR>
    such&#8239;decrease&#8239;(or<BR>
    increase)</B></P></TD>
    <TD STYLE="width: 1%">&#8239;</TD>
    <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; border-bottom: Black 0.5pt solid"><B>Signature&#8239;of<BR>
    authorized<BR>
    signatory&#8239;of<BR>
    Trustee</B></P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&#8239;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ASSIGNMENT FORM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To assign this Security, fill in the form below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">I or we assign and transfer this Security to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 100%; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    or type assignee&rsquo;s name, address and zip code)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">&#8239;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Insert
    assignee&rsquo;s soc. sec. or tax I.D. No.)</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">and irrevocably appoint <U>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</U>
as agent to transfer this Security on the books of the Company. The agent may substitute another to act for him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 50%">&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your Signature*:</FONT></TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD STYLE="font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD>&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Sign exactly as your name appears on the other
side of this Security.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*Signature Guaranteed:</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; font-size: 10pt">&#8239;</TD>
    <TD STYLE="width: 45%">&#8239;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">*NOTICE: The signature to this assignment must
correspond with the name as it appears upon the face of the within Note in every particular, without alteration, enlargement or any change
whatever. Such signature must be guaranteed by an &ldquo;eligible guarantor institution&rdquo; meeting the requirements of the Security
Registrar, which requirements include membership or participation in Security Transfer Agents Medallion Program (&ldquo;STAMP&rdquo;)
or such other &ldquo;signature guarantee program&rdquo; as may be determined by the Security Registrar in addition to, or in substitution
for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 91; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-7-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#8239;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>tm267894d1_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT>[WLRK Letterhead]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">March&nbsp;4,
2026</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AbbVie Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 North Waukegan Rd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">North Chicago,&nbsp;Illinois 60044</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have acted as special counsel to AbbVie Inc.,
a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the issuance and sale by the Company of $750,000,000 aggregate
principal amount of its senior floating rate notes due 2028 (the &ldquo;<U>Floating Rate Notes</U>&rdquo;), $1,500,000,000 aggregate principal
amount of its 3.775% senior notes due 2028 (the &ldquo;<U>2028 Notes</U>&rdquo;), $1,250,000,000 aggregate principal amount of its 4.125%
senior notes due 2031 (the &ldquo;<U>2031 Notes</U>&rdquo;), $1,250,000,000 aggregate principal amount of its 4.400% senior notes due
2033 (the &ldquo;<U>2033 Notes</U>&rdquo;), $1,500,000,000 aggregate principal amount of its 4.750% senior notes due 2036 (the &ldquo;<U>2036
Notes</U>&rdquo;), $1,250,000,000 aggregate principal amount of its 5.550% senior notes due 2056 (the &ldquo;<U>2056 Notes</U>&rdquo;)
and $500,000,000 aggregate principal amount of its 5.650% senior notes due 2066 (the &ldquo;<U>2066 Notes</U>&rdquo; and, together with
the Floating Rate Notes, the 2028 Notes, the 2031 Notes, the 2033 Notes, the 2036 Notes and the 2056 Notes, the &ldquo;<U>Notes</U>&rdquo;).
The Notes were sold pursuant to an Underwriting Agreement, dated February&nbsp;24, 2026, by and among the Company and J.P. Morgan Securities
LLC, BofA Securities,&nbsp;Inc., Morgan Stanley&nbsp;&amp; Co. LLC and Wells Fargo Securities, LLC, acting for themselves and as representatives
of the several Underwriters named therein (the &ldquo;<U>Underwriting Agreement</U>&rdquo;). The Notes are to be issued under that certain
Indenture, dated as of November&nbsp;8, 2012, between the Company and U.S. Bank Trust Company, National Association, as successor-in-interest
U.S. Bank National Association, as trustee (the &ldquo;<U>Trustee</U>&rdquo;), as supplemented by that certain Supplemental Indenture
No.&nbsp;12, dated as of March&nbsp;4, 2026, between the Company and the Trustee (collectively, the &ldquo;<U>Indenture</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm267894d1_ex5-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AbbVie Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March&nbsp;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Page&nbsp;</FONT>2</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We have examined and relied on originals or copies
certified or otherwise identified to our satisfaction of such documents, corporate records, certificates of the Company and public officials
and other instruments as we have deemed necessary or appropriate for the purposes of this letter, including (a)&nbsp;the registration
statement on Form&nbsp;S-3ASR (File No.&nbsp;333-284980), filed with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
on February&nbsp;14, 2025 (the &ldquo;<U>Registration Statement</U>&rdquo;), but excluding the documents incorporated therein; (b)&nbsp;the
base prospectus, dated February&nbsp;14, 2025, included in the Registration Statement, but excluding the documents incorporated therein;
(c)&nbsp;the preliminary prospectus supplement, dated February&nbsp;24, 2026, as filed with the Commission pursuant to Rule&nbsp;424(b)(5)&nbsp;under
the Securities Act of 1933, as amended (the &ldquo;<U>Act</U>&rdquo;), but excluding the documents incorporated by reference therein;
(d)&nbsp;the final term sheet dated February&nbsp;26, 2026, as filed with the Commission pursuant to Rule&nbsp;433 under the Act; (e)&nbsp;the
prospectus supplement, dated February&nbsp;24, 2026, as filed with the Commission pursuant to Rule&nbsp;424(b)(5)&nbsp;under the Act,
but excluding the documents incorporated by reference therein; (f)&nbsp;a copy of the Amended and Restated Certificate of Incorporation
of the Company and a copy of the Third Amended and Restated Bylaws of the Company, each as set forth in the certificate of the Secretary
of the Company, dated the date hereof; (g)&nbsp;the Indenture; (h)&nbsp;a copy of the Global Notes for each series of the Notes, each
dated as of March&nbsp;4, 2026; (i)&nbsp;an executed copy of the Underwriting Agreement; (j)&nbsp;resolutions of the Board of Directors
of the Company relating to the issuance of the Notes; and (k)&nbsp;such other corporate records, certificates and other documents and
such matters of law, in each case, as we have deemed necessary or appropriate. In such examination, we have assumed (i)&nbsp;the authenticity
of original documents and the genuineness of all signatures; (ii)&nbsp;the conformity to the originals of all documents submitted to us
as copies; (iii)&nbsp;the truth, accuracy and completeness of the information, representations and warranties contained in the agreements,
records, documents, instruments and certificates we have reviewed; (iv)&nbsp;all Notes will be issued and sold in compliance with applicable
federal and state securities laws and in the manner stated in the Registration Statement and the Prospectus Supplement; and (v)&nbsp;the
Underwriting Agreement has been duly authorized and validly executed and delivered by the Underwriters. We have assumed that the terms
of the Notes have been established so as not to, and that the execution and delivery by the parties thereto and the performance of such
parties&rsquo; obligations under the Notes will not, breach, contravene, violate, conflict with or constitute a default under (1)&nbsp;any
law, rule&nbsp;or regulation to which any party thereto is subject (excepting the laws of the State of New York as such laws apply to
the Company); (2)&nbsp;any judicial or regulatory order or decree of any governmental authority; or (3)&nbsp;any consent, approval, license,
authorization or validation of, or filing, recording or registration with any governmental authority. We also have assumed that the Indenture
and the Notes are the valid and legally binding obligation of the Trustee. As to any facts material to the opinion expressed herein that
we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives
of the Company and others. We have further assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity
of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, facsimile,
conformed, electronic or photostatic copies, and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We are members of the Bar of the State of New York,
and we have not considered, and we express no opinion as to, the laws of any jurisdiction other than the laws of the State of New York
in effect on the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">Based upon the foregoing, and subject to the assumptions,
limitations, qualifications, exceptions and comments set forth in this letter, we advise you that, in our opinion, the Notes, when duly
executed, authenticated, issued, delivered and paid for in accordance with the terms of the Indenture and the Underwriting Agreement,
will be valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm267894d1_ex5-1img001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">AbbVie Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">March&nbsp;4, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">Page&nbsp;</FONT>3</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">The opinion set forth above is subject to the effects
of (a)&nbsp;bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar laws relating to or affecting
the enforcement of creditors&rsquo; rights generally; (b)&nbsp;general equitable principles (whether considered in a proceeding in equity
or at law); (c)&nbsp;an implied covenant of good faith and fair dealing; (d)&nbsp;provisions of law that require that a judgment for money
damages rendered by a court in the United States be expressed only in United States dollars; (e)&nbsp;limitations by any governmental
authority that limit, delay or prohibit the making of payments outside the United States; and (f)&nbsp;generally applicable laws that
(i)&nbsp;provide for the enforcement of oral waivers or modifications where a material change of position in reliance thereon has occurred
or provide that a course of performance may operate as a waiver, (ii)&nbsp;limit the availability of a remedy under certain circumstances
where another remedy has been elected, (iii)&nbsp;limit the enforceability of provisions releasing, exculpating or exempting a party from,
or requiring indemnification of a party for, liability for its own action or inaction, to the extent the action or inaction involves negligence,
gross negligence, recklessness, willful misconduct or unlawful conduct, (iv)&nbsp;may, where less than all of a contract may be unenforceable,
limit the enforceability of the balance of the contract to circumstances in which the unenforceable portion is not an essential part of
the agreed-upon exchange, (v)&nbsp;may limit the enforceability of provisions providing for compounded interest, imposing increased interest
rates or late payment charges upon delinquency in payment or default or providing for liquidated damages or for premiums upon acceleration,
or (vi)&nbsp;limit the waiver of rights under usury laws. Furthermore, the manner in which any particular issue relating to the opinions
would be treated in any actual court case would depend in part on facts and circumstances particular to the case and would also depend
on how the court involved chose to exercise the wide discretionary authority generally available to it. We express no opinion as to the
effect of Section&nbsp;210(p)&nbsp;of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">We express no opinion as to whether, or the extent
to which, the laws of any particular jurisdiction apply to the subject matter hereof, including, without limitation, the enforceability
of the governing law provisions contained in the Notes and the Indenture. We express no opinion as to the ability of another court, federal
or state, to accept jurisdiction and/or venue in the event the chosen court is unavailable for any reason, including, without limitation,
natural disaster, act of God, human health or safety reasons or otherwise (including a pandemic).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">This letter speaks only as of its date and is delivered
in accordance with the requirements of Item 601(b)(5)&nbsp;of Regulation S-K under the Act. We hereby consent to the filing of a copy
of this letter as an exhibit to the Company&rsquo;s Current Report on Form&nbsp;8-K, filed on March&nbsp;4, 2026, and to the use of our
name in the prospectus forming a part of the Registration Statement under the caption &ldquo;Legal Matters.&rdquo; In giving this consent,
we do not thereby admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">/s/ Wachtell, Lipton, Rosen&nbsp;&amp;
    Katz</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>abbv-20260304.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaKPubOdzZR+SYkxtmB7bSm6LyIuGWTeRSajOI82EYIO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:abbv="http://abbvie.com/20260304" elementFormDefault="qualified" targetNamespace="http://abbvie.com/20260304">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://abbvie.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20260304_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20260304_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="abbv-20260304_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="abbv_SeniorNotes0.750Percentdue2027Member" name="SeniorNotes0.750Percentdue2027Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.125Percentdue2028Member" name="SeniorNotes2.125Percentdue2028Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.625Percentdue2028Member" name="SeniorNotes2.625Percentdue2028Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes2.125Percentdue2029Member" name="SeniorNotes2.125Percentdue2029Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="abbv_SeniorNotes1.250Percentdue2031Member" name="SeniorNotes1.250Percentdue2031Member" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>abbv-20260304_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="abbv-20260304.xsd#Cover" roleURI="http://abbvie.com/role/Cover" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://abbvie.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="loc_deiEntityListingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityListingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="loc_abbvSeniorNotes0.750Percentdue2027Member_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes0.750Percentdue2027Member_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2028Member_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2028Member_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.625Percentdue2028Member_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.625Percentdue2028Member_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2029Member_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2029Member_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="loc_abbvSeniorNotes1.250Percentdue2031Member_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes1.250Percentdue2031Member_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_deiEntityListingsExchangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiEntityListingsExchangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS" xlink:label="loc_exchXNYS_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXNYS_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XCHI" xlink:label="loc_exchXCHI_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXCHI_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications_90" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial_90" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer_90" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_90" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle_90" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag_90" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol_90" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName_90" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle_90" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation_90" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm_90" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_90" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_90" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers_90" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_90" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_90" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory_90" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness_90" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_90" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod_90" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard_90" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_90" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany_90" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat_90" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_90" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_90" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_90" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>abbv-20260304_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis" xlink:label="dei_EntityListingsExchangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsExchangeAxis" xlink:to="dei_EntityListingsExchangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsExchangeAxis_lbl" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS" xlink:label="exch_XNYS" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="exch_XNYS" xlink:to="exch_XNYS_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="exch_XNYS_lbl" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XCHI" xlink:label="exch_XCHI" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="exch_XCHI" xlink:to="exch_XCHI_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="exch_XCHI_lbl" xml:lang="en-US">NYSE TEXAS (Member)</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="abbv_SeniorNotes0.750Percentdue2027Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes0.750Percentdue2027Member" xlink:to="abbv_SeniorNotes0.750Percentdue2027Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes0.750Percentdue2027Member_lbl" xml:lang="en-US">Senior Notes 0. 750 Percentdue 2027 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="abbv_SeniorNotes2.125Percentdue2028Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.125Percentdue2028Member" xlink:to="abbv_SeniorNotes2.125Percentdue2028Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.125Percentdue2028Member_lbl" xml:lang="en-US">Senior Notes 2. 125 Percentdue 2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="abbv_SeniorNotes2.625Percentdue2028Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.625Percentdue2028Member" xlink:to="abbv_SeniorNotes2.625Percentdue2028Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.625Percentdue2028Member_lbl" xml:lang="en-US">Senior Notes 2. 625 Percentdue 2028 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="abbv_SeniorNotes2.125Percentdue2029Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes2.125Percentdue2029Member" xlink:to="abbv_SeniorNotes2.125Percentdue2029Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes2.125Percentdue2029Member_lbl" xml:lang="en-US">Senior Notes 2. 125 Percentdue 2029 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="abbv_SeniorNotes1.250Percentdue2031Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="abbv_SeniorNotes1.250Percentdue2031Member" xlink:to="abbv_SeniorNotes1.250Percentdue2031Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="abbv_SeniorNotes1.250Percentdue2031Member_lbl" xml:lang="en-US">Senior Notes 1. 250 Percentdue 2031 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="dei_EntityListingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityListingsTable" xlink:to="dei_EntityListingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityListingsTable_lbl" xml:lang="en-US">Entity Listings [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentInformationLineItems_lbl" xml:lang="en-US">Document Information [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>abbv-20260304_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.4b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="abbv-20260304.xsd#Cover" roleURI="http://abbvie.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://abbvie.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsTable" xlink:label="loc_deiEntityListingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityListingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiDocumentInformationLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes0.750Percentdue2027Member" xlink:label="loc_abbvSeniorNotes0.750Percentdue2027Member" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes0.750Percentdue2027Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.125Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2028Member" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2028Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.625Percentdue2028Member" xlink:label="loc_abbvSeniorNotes2.625Percentdue2028Member" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.625Percentdue2028Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes2.125Percentdue2029Member" xlink:label="loc_abbvSeniorNotes2.125Percentdue2029Member" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes2.125Percentdue2029Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="abbv-20260304.xsd#abbv_SeniorNotes1.250Percentdue2031Member" xlink:label="loc_abbvSeniorNotes1.250Percentdue2031Member" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_abbvSeniorNotes1.250Percentdue2031Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityListingsExchangeAxis" xlink:label="loc_deiEntityListingsExchangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsTable" xlink:to="loc_deiEntityListingsExchangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_ExchangeDomain" xlink:label="loc_deiExchangeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityListingsExchangeAxis" xlink:to="loc_deiExchangeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XNYS" xlink:label="loc_exchXNYS" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXNYS" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/exch/2025/exch-2025.xsd#exch_XCHI" xlink:label="loc_exchXCHI" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiExchangeDomain" xlink:to="loc_exchXCHI" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm267894d1_ex4-2img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm267894d1_ex4-2img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  R .D# 2(  A$! Q$!_\0
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MLN/[RXQGOP* /1J*9%*D\*2Q,'C=0RL#P0>0:?0!'/<0VL#SW$J10QJ6=W.
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J%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm267894d1_ex5-1img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm267894d1_ex5-1img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  9 3L# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^U/\ :_\
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MUAEU*^DD /[(=&_:(\%>(?VE?'G[+>BZ7XIU#QS\,?A#\/OC'X[\26]EI+>
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M\+:_XDM1IWP^\-_V]J.LV-IK%WJD L;F1O[7O+Z)!:SN?MDB2,<@'VC7RO\
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'V"BB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.4</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 04, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  04,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ABBVIE
INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001551152<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">32-0375147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1
North Waukegan Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">North
Chicago<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60064-6400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">932-7900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | NYSE TEXAS (Member)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member', window );">Senior Notes 0. 750 Percentdue 2027 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750%
    Senior Notes due 2027<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member', window );">Senior Notes 2. 125 Percentdue 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125%
    Senior Notes Due 2028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member', window );">Senior Notes 2. 625 Percentdue 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.625%
    Senior Notes Due 2028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV28B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member', window );">Senior Notes 2. 125 Percentdue 2029 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125%
    Senior Notes due 2029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member', window );">Senior Notes 1. 250 Percentdue 2031 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.250%
    Senior Notes due 2031<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ABBV31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XCHI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XCHI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes0.750Percentdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.625Percentdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes2.125Percentdue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=abbv_SeniorNotes1.250Percentdue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>8</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tm266774d4_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://abbvie.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>abbv-20260304.xsd</File>
    <File>abbv-20260304_def.xml</File>
    <File>abbv-20260304_lab.xml</File>
    <File>abbv-20260304_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="tm266774d4_8k.htm">tm266774d4_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm266774d4_8k.htm": {
   "nsprefix": "abbv",
   "nsuri": "http://abbvie.com/20260304",
   "dts": {
    "schema": {
     "local": [
      "abbv-20260304.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "abbv-20260304_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "abbv-20260304_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "abbv-20260304_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm266774d4_8k.htm"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 3,
   "memberCustom": 5,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2025": 4
   },
   "contextCount": 8,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 73,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 40
   },
   "report": {
    "R1": {
     "role": "http://abbvie.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-03-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm266774d4_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-03-04",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm266774d4_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "abbv_SeniorNotes0.750Percentdue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20260304",
     "localname": "SeniorNotes0.750Percentdue2027Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 0. 750 Percentdue 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes1.250Percentdue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20260304",
     "localname": "SeniorNotes1.250Percentdue2031Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 1. 250 Percentdue 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.125Percentdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20260304",
     "localname": "SeniorNotes2.125Percentdue2028Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 125 Percentdue 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.125Percentdue2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20260304",
     "localname": "SeniorNotes2.125Percentdue2029Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 125 Percentdue 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "abbv_SeniorNotes2.625Percentdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://abbvie.com/20260304",
     "localname": "SeniorNotes2.625Percentdue2028Member",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Notes 2. 625 Percentdue 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "exch_XCHI": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XCHI",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NYSE TEXAS (Member)"
       }
      }
     },
     "auth_ref": []
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2025",
     "localname": "XNYS",
     "presentation": [
      "http://abbvie.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001104659-26-023534-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-26-023534-xbrl.zip
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M*EDYP+X6,LBVI13UCC\)I%Z3.MFN9IS"FY(TA@YP#J$&:;>4C190Z0DOF#A
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M^%E>Z-D\ *MU=T"QPV(!A<NE[9]ZI3#EY9_EN?2X^J6^7E0>^1]02P,$%
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M"QWJ):A: %J(>\3R(M W40B2I>C>7UY==,8_\<7%(OYK@1/"E_P?4$L#!!0
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MHPR$\JA2-]7L<U'%7K;DC&.)H^Z</_9B3!37P[?Z@R;F;4:*^G*?570VE8E
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M(?[ V-O,U>NYMP#V-7(1B$FB8X?P?VCM;<+J*X8T%LB>%)@L,*5Z^0IBH&O
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M-%\X:RYH=&WM76MSVLC2_LZOF)=S]JQ3:RX2B(N=< HP=HBO 1P[J5/E$M(
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M:.,+J)D=-Z@O%-$$PB@+&<5HH3;MB6J'L%MNU DW<@O@'-C6H YK3K2MGFZ
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ME50?C,_OV\?M5L_W<.N$W;SS(&LVSH$%\F24 (N&I$'@ 0'>&X;CZ *^&WK
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ML J*Q0GV.I^FB$(TL%PNUG!L8RF>@TLR'429/J5I=':>,_"3.E+T;RN+6 L
M=LY?V3)@E27R8I'39_<K<OKL(7+Z"R[\\+8N?-.EKLJR;7\;A%," -;.2Y"@
M187WN6]=,G4GOVS2Z4(!<HGS9^;Z4F '4<JWH.\4%F!!F3<]O\JP%,3QD!7:
M[F6FKD<!/\,-"RM)Q2EN79AJ$:G.IF3 -=WQ1WS9E4[GD5P8<D6NLES[@3C7
M$KA4?<KB0P!"W(&VQ"T>XES?3;HJ[G9.ZV>P("OX/R4T$BKLURZ> H((*%)L
MT 84=X(3N\H5#JO4W 85/25"V&"0O;,T*7=#7JUG]Y6;I2Z258<Z*\DH E>
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M'JOZ*<T0/L%:6/B^\'0IF5X_V6Q8Q0HKS,R_/FM]72$&;BGG;VW)-;HM4_.
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MUFQ04D"2GL$5^U\I* R_P:X3U*!.0*3J!*JHA7\A>-J&9':!JDKUUO",5,J
M;2:<CB:9+I?A8A-$ U%%*YEJ@*% 5N16K 3IA6G5Y#;4* &;/HFF"TS+$31Y
MS.J32DHL+(XRKCV 8UAUYA!:?(O\O>KBP?'FG6S?T[)0D.^Q1"$K-*NBSB-
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M6:L-@2VX+M"%S$A@M.!\^6TY#2TDVO/HS/%^3X)OT01,6QQ*]885=YM"6R#
M>E7IA6J17(2ZC ^>)8;&Y^#=P$L$]B"0$ H(WL(> ^*K.?PW3),"LZE=4ZX2
MI1)5V$Z*>4H:;GZ9>!N[ZGTTNW>ZCZ=-*UMAS2I.N=/;RP*YJ-2(MT G%.@T
M4B"<E?@UDD7XF,(O3J6<5,Y9;@ZRP;%&+\#_U@0BA+=M"2&N8W@&859"U0)$
M]I'H.@RG(8E:4"95^G PO(A0EKBN636*#MFHMVP(*ATK18@)2.6&@76 #N6W
M]A':K*, @Y;B/IDHE,OZ9=M'& ,LCU-T#:,N&8WP\S!-T1@D1K%WI7K@NFM
MN;TK]P#QB@N;4$ DEGU05/"-B78:2:LV1A8;@& BIW9LF3=:JMC%G!4<H[OS
M;7EOQ9((+I*(P3M1!B6STYR(JT6+H&!5+UEO!PSF-%O4S6-X.:NLT2ZA8G1-
MVTFGT62S4=5ILGR>]9Y*XP_<=].7Q,($K^M,<H'S9\:9Q>+>T9VF-&8U';^2
M,\N!NM'W)OLU+6N=X-/(P4A.0 &7'/I2D8T&HM4;TXR8&R0<NN>OM!!P\"FY
MM]6^OK8)0">B7S%B=H6<)2?NF%RJYH?'X11,@-!R.52H8=;%DE/[ZS'!)SDT
M9:'%;H"KFA=4C:T!QHQFQ:VC]*^,<H)\],VF-'JIKO X#R,' $=-QD8^%E64
MQ L,PT6&Y)S%[<[PGO5=O&_5D7&QE:)/Q$RZ-<0C</VJY8I/%1?8"T]LHIBU
M;T07UA3-U#1-B#YP2U=O B)$)/B+,^] G.@5S(*QD)A\+X(-3U<5N0:Y><R5
M7V@&KKOZJ(:R>*N?)00^9.$0(>@?.3PD<HT^^T 32Q68D]8]AI7%''L4!5(\
M]BR4M9L'E3F8"/)]Q""]]7I.YF)5:?\;0RLEX^3,0=I2+A=J7L,P=LZN:-XD
M1;)(#9RE104TDO1QUH+/D7EXP<P1>#8.L+G$QM)I2_RPSJHE]EJZ)CD-0UTL
M%DZL45,BH"@L^DQT*]TPF)0).CTXU#@*+'@!A>$EX 7LF!M&J5#%U6?6Y#IK
M%6GNZZX#C/0QEM7;<"#5N^(H+Y7G:Y[,)^.P\M#[J-?:7:U<#:W4*TN+2G,R
M+> &^R9"+V+\N(B=K'I-V-H;,=U0^8EY$J8W Z%:D^ ?I:CW<=@M^*HF+%>B
M'-Y,T=37!HJET^'X6MVKU%(5\ EO@R06R39HJ(["=NC/$>,0>!H4T5!!G9$K
M&*F(2U5$QCROLV+G:X.BJ%/$DD)06*\)#%\;:U1W#H #1F8$DLB(,M(6MKPZ
MY:I"K,B+60 U&Y:QI$]WN1%GX;R7>$DQ=A7B_4*,+LA%W\GI:R)3;DQ%UAO(
MC2EP]\:AWCK8--Y,'\'TQH+/,@0MD6X3W"2"8<+(>9B2^<@W/%\?PUG.O;25
M;Z[(W)Q7!W/ SBT*[;"@<9=U;*T<61?Q F+-?17.4];DV^NDQ?DL!U@9-*U=
M8PU&H2'@JY5R:N=!@0<YZR#9U"7GVS")OM4,Q^YMJ4,<#*N5AY,I:^9R)10:
M[VER4M,)082W^O5)/(O<2_02D<2DN_ NU4B&(CM]%RM52$_0S%5?1R"S@ 73
M'_P#"=6YQKI\:VV=84<1TO8"K[/]8W)>T/0M./\EEEYG8L)Q0%=7%DJHDFS,
MRCO$FJX(^D ?A+M@U2\8IWIZ7T)2NP\AJ5\3DJ($.^/F++KVW92\BM[8M<Y[
MG]+PLT(K.?%^HXJEVJAI"[8N&8SN9N-(T;WNK%=OH"NJ:GH292FYWS$_WE>:
MGC6+JFRU3;*EP;Y&?'5GMC$0E8W6D'Y<G6Q2-6$WJE!H5<T)E%G.O^(9^X9F
MUN7LBX:[Z&NCR01F"M]2@!_(K'&N)UBQB5<A!R-XP5YAO<Y#JRQ>ES@$A.WI
MZ$E8D;H>:ZN+A#8;\T.AE5%G91#J\&91O:28)(7:R*FT54CP=2BL@R@Z\KU0
M++NBG1?[@A ;D%"M02F GV!$1T"T27'%K["3#>8"GX5Z*2G/"3UOS8;VRFGP
M^#@,B "HWYW#DZ 1/D93,8/!&2 [L$>E6+;O 4-AZP;D(M_;VWKQ;._EB[V_
MDH-[:WN/_\3@',Y))N -DTO2?N3QOS8;]N.;)*/DN]_<H7XK#C6;FH'<9W_;
MW/S]9_!UE?)PHZ7G>&@_OO-ZQP?PLLGN\Q>_O7PZW/G?\-O3Q[O1Y&Q[9^L_
MT[-'7NM#_Q^/[A#(CX:\I[RWG[)5MR^"E SH8 TVB0GTQWQ[W3O9?]/+P>9[
M_03_R=78'2,5(A8EYA>2F:_,(O1-2U+X=\?,W1N0@0SI^I,[6#FQ\<)U9.%-
MV@$KNC?M>+@R.U.IWR"$[ICKPE4PH;A+*#;7<*>&M$&#^=MC-:-RLJ1%U;0\
M0$>G</-?\"W[B7,0UH-HF$*@6A!1]H H&.24+65<&67%.@E&3V%KIFQDH =C
M0;:^38F^&$[!Y\YA__T_'A&6UJV PL!M>RTT01DR26GB!!Q0\>TN]ZS<V2P^
M47E[%H33='8ZCK)S<>:1G,#]8L-^T?]=O[G<P0\&9V$(YTN5&^%\5!>AXQ#/
M6L@)E,"20.OE)H)9;=H)]CD\S2*,^^3>WN_;V]YT:Z+ 'C9T"ASF76ZJ^H(Y
MK+K</)RE%W(-+>(?.B$,9"<[?^H5F,$&+<+&BG@X(=]U0G87.R'1J'B#.SU8
MX: )\0C5>3G&&"92>)$E<@BP)HRJ,( *UX2?R!639_/3:9:;#[E"*.QF4H6*
M,IPO@!PSBXHVK5.)5$BY7FXB;E-N?5ZL33AQ CCJWM&M*S+)T/YI)^8G^;B?
MW1<?]]Z#C_O7:<XG;XI61+/AWDXH*6R%3Q3IFTC.YMUCMUK%--;'F6JH7;8J
M'*=?Q-WJE! &5:C2YZALRF+>\'5AA,4WS7&%+N@>4(6VQ=G6>,W+YFN)[[@"
MNC(??-T8H\+_6[:HT(? X2/R)^,.84R?.J2=G>M,?W1[XH94Z/@X@KB1YRC?
MI")C%;5420S1/"0P&9.59=)D*4?92E)T'M_T%U#V*_7WM=OB18]80=JJC9?B
M-*[)ZF'(:8B9)?!O4,P"0=\:<B9-994LJ%,PT933.C2F?+/Q$38Q!/72KE##
MCK((WC#,6%[P4?]&FC#EB0U#S$S1%;NHGDX("X+*DZ@VVL@IS"--V04V*G@?
M@$N&Y'D Z4$$.C,7ARD!7A->F%.]P2?-+C"LR%1BM5MZJUDQI8I*MS6A6+<F
MSU&W;ZU-=%3):@;A)IJ?%:@M&')/)&D-<L(Q8N.0AHHK="L@&4-GDX_,CYMT
M%59:R4B;[[W+I2S$KKBTQK>,*)-4)XA$JC@1^(LP@70[0&3!0LZW"@QPD,".
M"PBJPW4EC6O"K7//=TV0]KJ= 0G/]+\9=FHV"E9_91%>M=IY;6&J+OV-"54'
M+GNW\I<D%L$VL;A;M&Q'ETY*"'WUN:6<35'KT5B?O KL=NK5!S,I([$NGH::
M#OK'C,XJW!:(5F*#I-1;#%)S/?^H<#;QHJ(79U4K?IT@24'\*AVNHK>JRA?!
M:\S7:I(5?:JR^ 0$B*TAY",AF0:,\FTI#+.$6R]F4)HA/'%%E>TR/ST^5]VP
M/JJT#_9W5F>4<![)2.UD"Y0U[$;)YB:=6BF-<Y*%:=+R8[^\QY?BL5>E7 N8
M)KEWGN?3[/<G3RXO+[?B\/(*/A^%PZTD/7LR88WV2:KNZL=(E.Q),.3"O6#\
MV,J.?AR<)K/\<>%AG]C5@=;SLF26#D)3A>LHLN=19L2V[^GA='#1(9C>##L]
MA_.M>0<L6I*R(SQF:XC,&R4VDWM$F%5^5W8\J-\IV7H)NYVIQ\5)X'M[VX]]
M[R7^'\QNWOEM^[$;.:UX^P0T^.$6]GIFGP.R'A>S%LQ=//>1B=>J^$>%L]P4
M?X#)TVS(.)'\PE<4+B_2]XIO<FWAPD@U9Y7SN#37&@^-+J]C-XAQC2SH [/.
M-;WC$H'+BJ=C4<.YV;@[EG/Y?FQ3X1&NJUYXK]55.<<60> !;8S<HC%18><4
MS1O7&UFNOQ+^-Z]45:$$[%*OY)&J*)**2U# 5'G,97UV*3$=?&Q1K66MG=]2
M4$?=R?(A=V<;JZ,OJH(,7S)H8OH4RW I'L$>SI4V4Q8,*SV_+V&EIP]AI5\@
MUJJ+TJ.)0AS60!=UE<..6-PHR,5-JUR45%WR>B/N!I;S+HP_P,6^)-Y0AL _
M5OE@_XK2\#+AW3B]Y6>ST!:N+_4&@H<Q%J4L5_"]8+VWMVBYMT PWUJ]M_[5
MO'KOC2(J@OIFLUCR[?]@S7?)%6IPBM"7WVQ<4_2=ST,L<@$NN"I\/4Z3L5:T
M9'$B=)+ZJ!'K_**__I5!"\4#QT@F-Z3(\0:B)(237>>=J*ATKE>UQ%LLJ]8?
MNY81KKGHJZB&I%E?)K WH\P0ECGH(,JX1>LHC8:$Z#1.+ED<#X*XIMZG5B@'
M64G_=F&!D%4>\FMKLP=?W'2"+3NW?_<V KNZ4_%!**",R^3'86S5-! (+(Q_
MOJ2XIE^':PW7'*N E?%"!&-O/QE>"?3C<O.P@Q.CN7*$I-C&J4V :CEF,*M>
M/:2[WB3#+ICO6L^PG=YARWL+\OX4#+SE^.18J6!+<L!#SO,-,\'>BDNM12XW
M#KP[@F>Y><R14F?1!>K.PQDISMB!6'IE2:Y5)-DRCX,!YMU@?RH)K!@P@&6F
M(G@Q"TM1_)J\R$-J:_,8M)*$S"H,J:C6G\OO3$Q]0H/<1I]>^K3>G63KF]/T
MF@VS_E(!U$]4^IJ-"JVO9!\\*'T_4>GC'"S+E>' ,2\I)CQJBD58P:D7AV?,
M25P^!9\@O#8#>C*$),D)'11$7.74S@D2.$F:X9(3T<OQ;TSQU+A12TW$6)HG
M,<^JSC1^T"-_A1XI>777[-.2:J0ES[!![/_-H@L,.^LZ(4=%):W3RG9SOWS0
M,E=#R_SI8O)[5<_EIK*\(EFBQ!QYOJ3>72O\G;<IU=-!?Q[-T4:7FX6.^RPA
MNA?2=Y=T6:"^7M9W[X[RNF!(]\5]">D^>PCIKJ!95 ZP+H@/41, IE9RX> \
MQHO*MZN)1-HG4Y&PH%9*7]9F8\-$(56O5@W.;Y(20<BIC"\WP=).AJO-F-.(
M?R0HHXGJ[S%*F16Y>8(M@"F34!H54JQ1.@!FMA]!TC95,B!&."?P1TZA-8J7
M\A "4NO28Q+D,$JV:<ITY%ICK"S7I8(A46P8K/K$3*=I,DTC:2:;AJ,Q;0^5
M?"53IYU!M=#&-%%/VOL19CWH_=R]R;3YDU(VSLGTIBF&6N'4$C9AH22C?L:<
M!&5-"A^?@FEMS['X"I4?ZU ,&]^.PD#CRBXP!3<5*TY*+\*[:V9 "JMI1>V@
MN;[3;D@LU"NT )L[#>I'J5%Y-4#;YOT(N7%E<+4+)@S2<21M-"DJJK;$0.%1
MZD!6B8I9K?L\N%)^CBNE@/8Y& =XI SJ!F*#ZG)EK"!91A=T+P+K'JB/QCO2
M'N/QQ$RNCWSX/9YQSAP_!<W8 X&9Z^8K_)E.JW3QNR4K4WJ24,.Y@M=V24 2
M@;TTE:*55;Z&/-A)+HAAJN,KU=2&R(F8J=3(EYO <\+#\INC7_1@H_\J-T[U
M^=LS1VYYW]V/'#D;<K!X7):VBI<Z6W?'0KRQVD0F,_>.$X=&&F6Z'?><1"2Z
M9C6B%[63'!+NEX ^T(W,O2']B@SS8C%%*85P7A*Y[OCN5FRX2>YSTMNM6A#[
ME6NB1\W=\5(=?ME2FD-SO'SF'&.[^ D(;Z6&C+-$\D5#[F.AGV1W#?4_&%]I
MYY7^Z9KL295N:\C7;"#]4+7-R[JMFP1K]ZU_T'%_^1V[H(X;+*#X+7>WV3=9
M31ND:Q0[L#^3&:/&D'W+W0OMWRPW(_2WDT)( 4*2SO2GI1ZZ,_#GZ9:O$#A<
MI=%B_=>RJB7FW8IGA+(=E+.@;@=\U@+8>5"':D/C+NL41T( 1T?QK)X6#Q',
M7Z'ZWOJQY&#+&<9TDA0KBH'CN16SKOV>>TA9"4(G>XI%X\O,Y!2K1=5;Y :Y
MJG@!-8W.DO&%?#^*J&4TW2'_F8$R.(RD1N(B_)XHOK,^-1_[_7A3)>,9][B;
MY><)E2[4O_]'9%3I_8R>-$AF*7=[B[GWI;P_BR;1.$@= J65\UW2,*E<2A5U
MI/8_)W^R=O7.9YI;%ML/4OO!9_&K\PI67G!;VM7R1Z P%//V.(G/J)/P%.0/
MEU1>W*&8=E78>,$X]V_W)<[]_)[&N:MY8R6L=<HH.S3^D9JZK]WM[>=>\5D+
MT4,D"@$9Q2J&W;L,IASA/83I7M"!=M 8?2%!)QYLZ1)5?<71Q9<G/B4&!Y*+
M27ZMJ51=AT-3\NQ)Q;-?'LBX?V!2ITGR=<SIRP5XL*$U20MA=%UKJ@L\4)%5
M6,,+U^2[+9/"=IG,QD-!X!O13IDML)K%9MKOQ@B)*A/2YD4&M+'RS6=3<=V6
MBJP99(J"RW0=LG>XRJGD5BVXF5]2\KWFW'#LAJ1M/D@UZ/+W;*,W9Q=-V7;U
M)H)$*._BD'WFRVTBIZ$8!.?BUW5'8^UVW8T?7 _8/!\KIXSC7414E&:A.@@>
M%8> 1XNHGWSRY[8;X>CQ[KQ1,7.F"D^4;Y'Z@I42E!'#5TI0B5EV?EBIG%"V
MAFQ442/1;&"11'5B2PD#+ E2A+D8/A$6NAXR3SP<DTF4Y]A)6CP\((M 94C2
M3'<'!S&/73SJ8,*7?7.MQK)VNUI=]E"-%F#M;5VZF"UK%ZC(6P=:&O$*$@BY
M!)@0,50TW/-HEE+6G(5<7.I:;ZKNY%),0^J>3@,F(^5,JQB*,2X4)I@.CRJ\
MH6:#PMLBPT#;!KEI7D;V.F) XO:LR7Z<<(LB=CZG\!RZ542UF&$H,5=^%J)M
M;(HMPF^P'5:Q13_%@Q&R:I-*G)XSF6B/"2T8KXR  6H*6TH;@U?2*:/)YV,:
M C4<5*9CT(UR#AZ+@:5 OQ,LMT2E.B+QEH"]<L:^' 4I*=N\RCNVH(/DY7UQ
MD+RXIPZ2GP7'V>EZGSO];KO7\SZ_;Q^WC]ZZN&P4*\#TL"&=4T2)S/)T-I'Z
M/#0P9ZA7B Q8[:.%"2VP4S+P"OX'%/K=[=WGOSQ%H^[XB^088-W6-(./U;]>
M>>+6IR@$G8XY,0,^<H_4(>H?FFG"O_6GWL$1SJK[CT=[2P<V0.+L[__1:7N=
M[H'E,E^%B=E#WN2DEI[(/C9DK5[7KE[7_,MB\;[F-[#N0@3I&7+:C9!"<^_3
M&Q_Q&8Q(=]I-S7 '!NP-@#1>?PLL!,S^^O6<-'<86V<8AZ-\<9YYY55&&_NH
M$_X@01^]:=.5A2ZU/["PYU,:8D$O6&[[1,>#\R@<F=Y)WA$:T6%:H+45@5O1
M.V\1=7)W^[ZHD[\]J).W&]W=?],_/NGUVVV!..V!;G'<[[SM'+3Z;>_HK=<Z
MZ;]O=_OX=^>H^_K)_AV >2_HS'TT6*.,$W/+(*G\B7AUAR%;NNAF4_4\MF$L
MI1CH40;F0;4:3&QJ@")F[8-&_:!1KXA&39@-^ZWN/STZXS#81QCKB^]UZ2RW
M/GBM7N_HH$-_^=[/T+JGV.<E/GN,>@6>SQU,*EI&*07S5OQ5#T;"@Y&P3D:"
M]^?-2-!__WH>O*%A;L9N>*#K+0WS9XM3J_\+ZH]86T4:K8FYM7-?S*V7#^;6
M;9M;?[X].OXH;P/SZM_'[3_:QSTRM7KM@Y/C3O_+W3"R%@E2]IU0H3'!@F:#
MPA"!D2!1ELVXF*!DFFGD%;''0-2.N23<L]K6Z9_9#>M\'G?(K?0H_B$?1-AR
M*J3>*U2I*?8?!RJ#V.[(,22D,\9V[287U$M;B/J;[^UN[^SZ%'+6?5N<_$Z,
M94KJ9RG54RV)&CR6UZ3GX"[I-,POP]!I74+K8WT?<SQ(15;?@;X?2.JHG;F*
M4]:)'[!QCPUX,LS.C%7[XUSBQG.W12OK)V\TA(  6X3I1!4<9\4T%/Y5LU$1
M-][DAI8]36.8F@DJ=Y,MV1K<%7OG/@;IX%R^>XK;MOO\&HZRWM!LU.Q%,$DD
M#\3>"2NL[N->\XHMEJJ9/37(&8^]2'V26;Q$/4DY/\=4<1>R,:0'O55S(?V?
M.?D-O:?4F0F.]CB:1-SUB<BC/A[.Z.A1OY/)9!;S2:3W\F:H#L&:N^P< K7X
M.3UIW"PZ0L\2?$-@B(SS)0WTR9Q? ATQR6"(_^*S[7M6ZH,<^F$XAE6GV/:R
M3AI5NG]4ALH(N^"I]!0"=U%M9;S@["S%W&#@TVD*G!Q-\4,"",-A__+BV;:_
MO4W_?Y6]0C\BSS'O V@;AA-.*-:(#IAH.,&$D6AMF@[UY[$C7&@)=TF6*C0Y
MB%%,X'(C.#MK0H8.9:!S5R2@P6$X"F9C3CY'S C3?[GVY'+*$(. 4<>N4-7Q
M :E8GICS=*T$D3MW& [& 3IIA[.0Q8+J<"\N6X7F%@\-"JKDB^E>4/+HG7#F
M+LFYYI)!6@=1;+5$SAAT9!@B^A[!D2"D'X(]1A,M(5&L8ADGC',*\I'ZY)82
M_#!-%:SA@*%C\C3B.V< 6E,<(/ %DK]]H7 6;>8Q6#-5?>RX[3TA(-$-@3V:
MQY%I@:W>"HL;2B:^R?]3X$$X(G^WL[>U2W.!?^RI%5KW,!8"Z,S&6MY;2_;
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M$$F_Z?UM,@RR\U?>^RW8=#' -K#4Q+6XU-@1I_]S\0G]N:FQ"ZTA-JU,X$'
MU):GYC"&FHMF<+QB\P#K!.4RMY_J8B5%,+8F7; 2U8L11CX,D /<N7K]@X]J
MOEM 'WTR%$2D=;34E)J-8U5=H$\-GZR,",WXAOIWOQ=*,9BY%$N5UFET%I@V
M35'!WCKZ)BBP40*,0LIU)5.K6@:S@(]+:4/>AF7K'FN=[D,T"A7%7KDU.=%(
MK$\TG&(I&_W>!;IO9&JC))0CJ3@ [3.FJ,$P)75,EZQ<^WJ[.B@[3])<0P*A
MX5D]OK?P\,V&/?XXB<]L["-WE7I5^&9F*;K&I\GX)G84=%32;_,T0$O^\1@$
MI-)P45H*QU,%MQ?/T(>%(V M,!SF3(M/V0)M)!DXU6PVSNL,)F:6O1]E%F>'
M8,3Y%+7O:G7D<"'.<:Y_&55W9WDU3VYY;[FI,M>G*%KKJ]JO$R!5JTL=^686
MJR]L5&*I7 /+8(*"9>.<'%W=;[:031&ZT1 \HB"A?%V)/H\F1M(8NX/>OLHJ
MY(+1FYW[$KUY]A"]^?G&26=4K:,V&TLHJ;ZG]!41F"+XM-)8I9" =HD@W'E8
M*XJ.R3?)"K JU"/_A,)[<66+[1M!O(0+!!G)1<#",UI:@&*\L_/[]K87U)@/
M6F\'Y0]QQ^&)9F-IS;VRMEHO+E..7)X68BG&A%E!5I8E1!6"BLA[U!Z8G,M=
ML 6Y"@KER+/ON"6FR96.2VILIS,Q]]G?#=J2"EW-?S/^MD@2<Z^@=3:,^#;0
M@$??K83XI%)5OLWL=1WI;9"=RC!!W="6-?T=NUHZ6,T&J_H+,=]WKK5^0H:O
MP$1;>J,+3+:L58!*5.E]L"]S7F@A[@_@,Q@G,'X]?;SQ^H.[J-ZN8N;3T;2L
M:N%S)[+(9BE) #HR3<O2 $&QLSP%? K A)48 OYY&G% *<B^XE2F&'O(#)+3
M]7MSK=1<95UKF1MQGJ'=;+C>K1H'&<<":[1N^YXJ7TZR798,J]X:/.9.[?-I
MN P'>,( 3O3)NR[XM%G!!7(SVI?G:!&>NO(7"66M"5/UC=S0C28#1I9@S[AB
M.8EH1V4FM"P;VCNS[:"C#,:@F%QP3/,T8K.WB%( ]#[-N*UA#"8B"(XP39-U
M 88 &V*><P%Q2"JCW+L8W29C'=4ZA<BC0C,J>,OV=,::+66/N!=10*B78P(S
MZ)_7XU$V&QL&/QFVF)X*TJM-O[C'Y<O.&-RH2M1(GBG8=0.E<DS3!&XPRL,H
MB170F_3;UX0%3*"EY&E'N)<K*^)" .:<MF-C$>HKEJ$%>RB4X6-,>(GQ:V(3
M!#TZ1_.9O>?J7=:5R.J>I($0KF5*A7BG0?PU8[THF88QG5"-S5<YU)KL3'^^
MZV^8$,$%[D<E 47Q5Q)C0/HU(4,'X<&\]H5D-@FV(AU>Q/C38;]Z#9=E0#*
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M;$-Z#O$RG,?TU%%B.C=W##E,L.G"DN0EOK!C*?1H&:CB+ H5)7Q>3@K$4A"
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M1RUJ4>7J(,RJ7&T8J26\][WU="TT,K:*9Y? 32DA<(U4D,TLY)<194>)9SA
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M6$<7L3?5I)Z]?N/]F>J=(E 5ZE;@,$BN,5+1TD"4++R/>E'/ CE75+FJ^:,
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MHL^_-\'.VVE$!GJUS5@^#57"_,M)G SO-_U4T7Y[68IYFY/>J]?,MP4@*+E
MP@H1JAYYQ?Q?EK<WNZQ@U,*(>J([] KYZS&LY414L4%'3U<(:I3+@B/C,Q:N
MCN.N[3R[%Q%PF9&,"\9*.0M+;OD[Y'^CZH1*?[;)]K,8HNRWNT%*7/Z/[__
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M.TICL]A\66H!?9T'KNV(+5%22D0 GP1<TRBI[L1" =?*$/,88WUHKG O<^"
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M\F*6#2T[12II$;EHZDWDGQ]&.+>2O+?GQ.29U;+ E7"!=9]3\)R#*^:?^OF
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M.]&](RM:0:F[NKFVS=VHP L5!2=UVASGI';[XJKY$@LUJJ  T[,[ITV'>ND
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M@$H^A7EA:'<.,#BH$%5?UIF+%7L[>]#-YKX3@V&?K1&"LS^)N289?+^[RXL
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MP>%,PEF&J,-=*0<I4.\L',WA7YO$J4'UA(('"\"%W89R7UCRB(:*XE*)$%Q
M)K8K-M"I63,P5JA R9*1++!HG176>8GKOE532X](1Z*,C)Y&K!9KUM:I$C7-
M&]7;';GNVA [X==E*$F6,L^%OX8E<&G_CIJH=5O1$;.JEGKACYGF]U*Y&@,L
M$CB"1&.CRTX3\1LWB LE%<(1TU&C.A/3M$1\2&JJ2 P4#KNC9M<6!3PFCC1R
M5D33V)*'BEK>GR6S, N=/-RQS@-XZB'_/;JGUJ',0O:]F0XJZ)P[V:AELJA;
M9Q78L;$:L<0?72B4Q#60M9/^,;D-N4SV)EM<NRAW@1NU7"=MX3-MQ3J#?[Q&
M+*ZN<WLO:M]D111 =6GM K&=BZ;VP9:Q%^F4*.C5HPT=Y)J&XA\+2"5(SJ"7
MHYKOPWR990,;I_1R9"ELT5Z\^%!*1!?W4U-D*C<UR@/8NF6YK!5OSI:=Q;HN
M;=RE(NN6=5F;!<>IGGAE*1JD0A6%-'1S6)YV3.%/2(M<7BU=P;@\3KZMZRPA
M,ZJ@,4=D,ST45[5]F(W3I,L287M: LNJQW!M;4DQ+B [YA,(X5;E:9@#X*F8
MR+/S\17]1,^=1=KLP\Z&62>ZY/>!B DFIMJ3546!,8%+&<7/[\RBI0E%$.=M
MP,MX@K1BJNL^^D$P\^Y)@Q'=\-'4[DIUT-\LW($YSSG32;+URM ;P _DG5=0
M(7#1)54D%J&\@(KK*4[GG4%!;(.(N\[>Z0_ZX77V(RX2[Z&&[E6C0T-,^;9!
M%?' ,>/+-$]@*AW&QW/=]A6J YCV1L\Q.<&;E(@+;T !T<*-:$5<:9A0"T'(
M*P@Q!:%FZ<JJ^\:XH1L^:4TB3+6YO\Z$=0/RVJLF#@7,[W(.HC !E7>5D"?;
M3!#GM?("J9E/4^P=N?<9BABMR5,8LA>PLB1=?%Q5ZVN>U(5;R9+Y'FF-];5&
M>I_4,!2H76;VNJ24(U7YR<ON"ZC-]J40)61*TVG\F%^*KBYX&N:+?J@B;TH+
M>.T-.Z$)IA3Y2K!L^2NF'E=Q5@Z.-S3U>:6FXJ _"%];H/FRO4NZVOJI^R;$
M4O589=C<QGA3LY<K'B(4WLS;+5"LH23LD+0.&2Q7 97B!:'/G((8I?CN"ZYG
M6S_Y-UIH7_7 F#W$3EQ;I JS)+N:-I8;O&)A'K]!>!Z/W'.#VJHAELQ9^J<_
M%WP_\<9>\_?\;P_.<S%.9_9Z+2V;FRM[&Z/M;:73HTQL^@7&GEO"FT[,/_S
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M,S T7V1E9BYX;6Q02P$"% ,4    " !WAV1<,CGFO_T,   FGP  %0
M        @ $)#@  86)B=BTR,#(V,#,P-%]L86(N>&UL4$L! A0#%     @
M=X=D7&>WKUS]"   SF\  !4              ( !.1L  &%B8G8M,C R-C S
M,#1?<')E+GAM;%!+ 0(4 Q0    ( '>'9%RCE?I*[!T  /'8   1
M      "  6DD  !T;3(V-C<W-&0T7SAK+FAT;5!+ 0(4 Q0    ( '>'9%Q&
M!\K?O 4! $'Y!@ 4              "  81"  !T;3(V-S@Y-&0Q7V5X-"TR
M+FAT;5!+ 0(4 Q0    ( '>'9%SMW),/MA$  %P_   4              "
M 7)( 0!T;3(V-S@Y-&0Q7V5X-2TQ+FAT;5!+!08     !P ' ,L!  !:6@$
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>tm266774d4_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:abbv="http://abbvie.com/20260304"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:exch="http://xbrl.sec.gov/exch/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="abbv-20260304.xsd" xlink:type="simple"/>
    <context id="AsOf2026-03-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <context id="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <context id="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XCHI</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <context id="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes0.750Percentdue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <context id="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <context id="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.625Percentdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <context id="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes2.125Percentdue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <context id="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001551152</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">abbv:SeniorNotes1.250Percentdue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-03-04</startDate>
            <endDate>2026-03-04</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-03-04" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-03-04" id="Fact000004">0001551152</dei:EntityCentralIndexKey>
    <dei:Security12bTitle
      contextRef="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember"
      id="xdx2ixbrl0046">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember"
      id="xdx2ixbrl0047">ABBV</dei:TradingSymbol>
    <dei:DocumentType contextRef="AsOf2026-03-04" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-03-04" id="Fact000011">2026-03-04</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-03-04" id="Fact000012">ABBVIE INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-03-04" id="Fact000013">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2026-03-04" id="Fact000014">001-35565</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-03-04" id="Fact000015">32-0375147</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-03-04" id="Fact000016">1 North Waukegan Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-03-04" id="Fact000017">North Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-03-04" id="Fact000018">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-03-04" id="Fact000019">60064-6400</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-03-04" id="Fact000020">847</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-03-04" id="Fact000021">932-7900</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2026-03-04" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-03-04" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-03-04" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-03-04" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-03-04" id="Fact000026">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle
      contextRef="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000027">Common     Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000028">ABBV</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-03-042026-03-04_us-gaap_CommonStockMember_exch_XNYS"
      id="Fact000029">NYSE</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="From2026-03-042026-03-04_exch_XCHI_us-gaap_CommonStockMember"
      id="Fact000030">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000031">0.750%     Senior Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000032">ABBV27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes0.750Percentdue2027Member_exch_XNYS"
      id="Fact000033">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000034">2.125%     Senior Notes Due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000035">ABBV28</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2028Member_exch_XNYS"
      id="Fact000036">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000037">2.625%     Senior Notes Due 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000038">ABBV28B</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.625Percentdue2028Member_exch_XNYS"
      id="Fact000039">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000040">2.125%     Senior Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000041">ABBV29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes2.125Percentdue2029Member_exch_XNYS"
      id="Fact000042">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000043">1.250%     Senior Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000044">ABBV31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2026-03-042026-03-04_custom_SeniorNotes1.250Percentdue2031Member_exch_XNYS"
      id="Fact000045">NYSE</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
